# Chapter 125: Lewy Bodies

## The Biological and Neurological Basis of Lewy Body Disease

### Introduction

Lewy body disease (LBD) represents a spectrum of progressive neurodegenerative disorders characterized by the abnormal intracellular aggregation of α-synuclein protein into inclusions known as Lewy bodies (LBs) and Lewy neurites (LNs) (Pavlović & Pavlović, 2004; Bencze et al., 2017; Goedert et al., 2003). This pathological hallmark places LBD within the broader category of α-synucleinopathies, a group of disorders that also includes Parkinson's disease (PD) and multiple system atrophy (MSA) (Derouesné, 2006; Knopman, 2017; Yang et al., 2022; Goedert et al., 2003). The clinical expression of LBD is heterogeneous, primarily manifesting as two overlapping syndromes: dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) (Hanağası et al., 2016; Seppi & Rascol, 2007; Ince, 2011). DLB is now recognized as the second most common cause of neurodegenerative dementia in older adults, following only Alzheimer's disease (AD) (Donaghy & McKeith, 2014; Rojas‐Fernandez & MacKnight, 1999; Mosimann & McKeith, 2003; Johnson et al., 2005; Bencze et al., 2017).

The core clinical features of DLB are a progressive cognitive decline, typically with prominent deficits in attention, executive function, and visuospatial abilities, accompanied by a triad of cardinal symptoms: fluctuating cognition, recurrent and well-formed visual hallucinations, and spontaneous parkinsonism (Derouesné, 2006; Mosimann & McKeith, 2003; Pavlović & Pavlović, 2004; Mayo & Bordelon, 2014). The distinction between DLB and PDD is based on an arbitrary "one-year rule": if dementia onset precedes or occurs within one year of parkinsonian motor signs, the diagnosis is DLB; if dementia develops in the context of well-established PD (i.e., more than one year after motor onset), the diagnosis is PDD (Seppi & Rascol, 2007; Hanağası et al., 2016; Burn & Yarnall, 2015). Despite this clinical distinction, many researchers consider DLB and PDD to be different manifestations of the same underlying pathological process, representing a continuum of Lewy body pathology (Derouesné, 2006; Seppi & Rascol, 2007; Burn & Yarnall, 2015; Ince, 2011).

From a biological perspective, LBD is a multisystem disorder affecting not only motor and cognitive functions but also behavior, sleep, and autonomic regulation (McKeith, 2000; Knopman, 2017; Hanağası et al., 2016). The widespread distribution of Lewy pathology throughout the central and peripheral nervous systems underlies this complex clinical picture (Kon et al., 2019; Yoshimura, 1997). The neuropathological process is characterized by neuronal loss and synaptic dysfunction in specific brain regions, driven by the accumulation of misfolded α-synuclein (Bencze et al., 2017; Yang et al., 2022). This chapter will provide a comprehensive overview of the biological and neurological mechanisms underlying LBD, drawing upon evidence from neuroanatomy, neurotransmitter system analysis, genetics, molecular pathology, and neuroimaging to elucidate the complex pathophysiology of this challenging neurodegenerative condition.

### Neurobiological Systems

The clinical heterogeneity of Lewy body disease is a direct reflection of the widespread and variable involvement of multiple neurobiological systems. The deposition of α-synuclein pathology disrupts critical neural circuits, leading to a complex array of motor, cognitive, psychiatric, and autonomic symptoms (McKeith, 2000; Knopman, 2017). Central to this pathophysiology are profound deficits in key neurotransmitter systems, particularly the cholinergic and dopaminergic pathways, which are more severe than those typically observed in other dementias like Alzheimer's disease (AD) (Emre, 2003; Perry et al., 1990).

#### Neurotransmitter Systems and Neuropharmacology

A defining biochemical feature of LBD is a profound cortical cholinergic deficit (Pavlović & Pavlović, 2004; Perry et al., 1990). This loss of cholinergic innervation is often more severe than that seen in AD and is strongly correlated with core clinical features (Hanağası et al., 2016; Emre, 2003). Specifically, reduced choline acetyltransferase activity in the parietal and temporal cortex has been significantly linked to the presence of visual hallucinations (Perry et al., 1990). This severe cholinergic dysfunction is thought to arise from LB-related pathology and neuronal loss in the nucleus basalis of Meynert, a key cholinergic nucleus that provides cortical innervation (K. A. Jellinger, 2000; Pérez-Lloret & Barrantes, 2016). The cholinergic deficit is considered a primary driver of the attentional fluctuations, cognitive impairment, and psychotic symptoms characteristic of the disease (Emre, 2003; Hanağası et al., 2016; Arnaldi et al., 2012). This understanding provides the biological rationale for the use of cholinesterase inhibitors (e.g., rivastigmine, donepezil), which have shown modest but significant clinical benefits for the cognitive, behavioral, and psychotic features of DLB and PDD (Hanağası et al., 2016; Mosimann & McKeith, 2003; Derouesné, 2006; Gold, 2009).

In parallel with the cholinergic deficit, LBD is characterized by a significant loss of dopaminergic neurons in the substantia nigra pars compacta, which underlies the parkinsonian motor syndrome (bradykinesia, rigidity, tremor) (Jankovic, 2008; Goedert et al., 2003). This nigrostriatal dopamine depletion is a pathological hallmark shared with PD (Mizuno, 1997; Yang et al., 2022). However, the neurochemical disruption extends beyond the motor pathways. Dysfunction of the mesocortical and mesolimbic dopaminergic systems, originating from the ventral tegmental area and medial substantia nigra, is implicated in cognitive deficits (particularly executive dysfunction) and neuropsychiatric symptoms such as apathy, depression, and psychosis (K. A. Jellinger, 2000; Emre, 2003; Pérez-Lloret & Barrantes, 2016).

This dual neurotransmitter deficit creates a significant therapeutic dilemma. Dopaminergic treatments (e.g., levodopa) used to manage motor symptoms can exacerbate psychotic symptoms like hallucinations and delusions (Factor et al., 1995; Fénelon, 2006; Galasko, 1999). Conversely, traditional antipsychotic medications, which act as dopamine D2 receptor antagonists, are relatively contraindicated in LBD due to a phenomenon known as severe neuroleptic sensitivity (Derouesné, 2006; Mosimann & McKeith, 2003). In up to 50% of patients, these agents can precipitate a catastrophic reaction characterized by worsening parkinsonism, confusion, autonomic dysfunction, and increased mortality (Mosimann & McKeith, 2003; Rojas‐Fernandez & MacKnight, 1999; Stancu et al., 2024). This heightened sensitivity is thought to result from the blockade of already depleted postsynaptic dopamine receptors in the striatum (Mendez, 2001; Factor et al., 1995). Consequently, when antipsychotics are necessary, atypical agents with lower D2 receptor affinity, such as quetiapine or clozapine, are preferred at low doses (Factor et al., 1995; Fénelon, 2006; Prakash et al., 2009; Ercika et al., 2025).

Beyond the dopaminergic and cholinergic systems, evidence points to dysfunction in other neurotransmitter pathways. Loss of noradrenergic neurons in the locus coeruleus and serotonergic neurons in the dorsal raphe nuclei is a common pathological finding (K. A. Jellinger, 2000; Pérez-Lloret & Barrantes, 2016). These deficits are thought to contribute to the high prevalence of depression, anxiety, and sleep disturbances in LBD (Emre, 2003; Hanağası et al., 2016; Mollenhauer & Weintraub, 2017). For example, abnormalities in serotonergic pathways have been linked to aggression, hallucinations, and psychosis (Assal & Cummings, 2002), while noradrenergic deficits may contribute to cognitive impairment and mood disorders (Pérez-Lloret & Barrantes, 2016; Hornykiewicz & Kish, 1984). The complex interplay of these multiple neurotransmitter deficiencies underscores the multisystem nature of LBD and explains the wide-ranging clinical symptomatology that extends far beyond simple motor or cognitive impairment.

### Genetic and Molecular Basis

At the molecular level, Lewy body disease is fundamentally a proteinopathy, defined by the pathological aggregation of α-synuclein (Goedert et al., 2003; Yang et al., 2022). Normally a soluble protein involved in synaptic vesicle regulation, α-synuclein misfolds and accumulates into insoluble fibrillar aggregates, forming the characteristic Lewy bodies (LBs) within neuronal cytoplasm and Lewy neurites (LNs) in axons and dendrites (Pavlović & Pavlović, 2004; Bencze et al., 2017; Ince, 2011). These inclusions are immunoreactive for both α-synuclein and ubiquitin, indicating that the cellular machinery for protein degradation, the ubiquitin-proteasome system, is involved and likely overwhelmed (Pavlović & Pavlović, 2004; Bencze et al., 2017).

Recent cryo-electron microscopy studies have revealed that the α-synuclein filaments from individuals with PD and DLB share a common structure, termed the "Lewy fold," which is distinct from the filament structures found in MSA (Yang et al., 2022). This finding establishes the existence of different molecular conformers, or strains, of aggregated α-synuclein in different synucleinopathies, which may contribute to their distinct clinical and pathological phenotypes (Yang et al., 2022). The process of α-synuclein aggregation is thought to follow a prion-like mechanism, where misfolded proteins act as a "seed," inducing the conformational change and aggregation of native α-synuclein molecules (Giubilei & Orzi, 2014; Candela et al., 2013). This seeding process may account for the stereotypical spread of Lewy pathology throughout the nervous system, as proposed by Braak and colleagues (Saito & Murayama, 2012; Bohnen & Shulman, 2019). This hypothesis suggests that the pathology initiates in lower brainstem nuclei, such as the dorsal motor nucleus of the vagus, and the olfactory bulb, and then propagates in a predictable, ascending pattern to the substantia nigra and eventually the cerebral cortex (Saito & Murayama, 2012; Kon et al., 2019). This anatomical progression aligns with the clinical observation that non-motor symptoms like olfactory dysfunction, constipation, and REM sleep behavior disorder often predate the onset of cardinal motor and cognitive features by years or even decades (Donaghy & McKeith, 2014; Postuma et al., 2012; Savica et al., 2010).

While most cases of LBD are sporadic, hereditary forms have been described, pointing to a genetic basis for the disease (Pavlović & Pavlović, 2004). Mutations and multiplications of the *SNCA* gene, which encodes α-synuclein, are known to cause familial forms of PD and DLB, providing direct evidence that an overabundance or structural alteration of this protein is sufficient to drive the neurodegenerative process (Goedert et al., 2003; Galpern & Lang, 2006). Other genetic factors have been identified that increase the risk for LBD. For instance, mutations in the *LRRK2* gene are a common cause of autosomal dominant parkinsonism and are associated with a wide range of pathologies, including typical Lewy body pathology, tau pathology, or even nigral degeneration without specific inclusions (Galpern & Lang, 2006; Saunders‐Pullman et al., 2019). This suggests an overlap in pathogenic pathways between different neurodegenerative proteinopathies. Similarly, mutations in the *GBA1* gene, which cause the lysosomal storage disorder Gaucher's disease, are a significant risk factor for both PD and DLB (Beccari et al., 2011; Stefani et al., 2025). This link highlights the role of lysosomal dysfunction in the clearance of α-synuclein and the pathogenesis of LBD.

The pathological picture of LBD is often complicated by the co-occurrence of other neurodegenerative pathologies, most commonly Alzheimer's disease (AD)-type pathology, including amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau (Dickson & Orr, 2011; Ince, 2011). A substantial proportion of DLB cases at autopsy show sufficient AD pathology to meet neuropathological criteria for AD (Gibb et al., 1989; Derouesné, 2006). This pathological overlap suggests a complex interplay between α-synuclein, Aβ, and tau proteinopathies (Galpern & Lang, 2006; Dickson & Orr, 2011). The presence of concomitant AD pathology is associated with more severe cognitive impairment and a more rapid disease course (Dickson & Orr, 2011; Kempster et al., 2007). The apolipoprotein E (APOE) ε4 allele, a major genetic risk factor for AD, has also been associated with an increased burden of cortical Lewy bodies and a higher likelihood of a clinical DLB phenotype, suggesting it may act as a common genetic risk factor for both pathologies (K. A. Jellinger, 2000). This molecular and genetic heterogeneity underscores the complexity of LBD and highlights the challenges in developing targeted, disease-modifying therapies.

### Brain Structure and Function

The clinical syndrome of Lewy body disease is a direct consequence of the topographical distribution of α-synuclein pathology and the resulting neuronal and synaptic dysfunction across specific brain regions and neural networks (Yoshimura, 1997; Kon et al., 2019). The pattern of neurodegeneration is widespread, affecting cortical, limbic, and brainstem structures, which explains the multifaceted presentation encompassing cognitive, psychiatric, motor, and autonomic features (McKeith, 2000; Knopman, 2017).

#### Brain Regions, Neural Circuits, and Functional Connectivity

Neuropathological studies have consistently shown that LBs and LNs are distributed throughout the central nervous system (CNS) in DLB, with high densities in brainstem nuclei (substantia nigra, locus coeruleus, dorsal motor nucleus of the vagus), limbic structures (amygdala, nucleus basalis of Meynert), and the cerebral cortex (parahippocampal gyrus, cingulate gyrus, insular, frontal, and temporal cortices) (Gibb et al., 1989; Yoshimura, 1997; Ishikawa, 1997; Jellinger, 2000). The degeneration of dopaminergic neurons in the substantia nigra disrupts the nigrostriatal pathway, leading to parkinsonian motor signs (Mizuno, 1997; Jankovic, 2008). This pathology also affects the mesocortical and mesolimbic dopamine systems, contributing to executive dysfunction and psychiatric symptoms like apathy and psychosis (Emre, 2003; Pérez-Lloret & Barrantes, 2016).

Disruption of frontal-subcortical circuits, which connect the basal ganglia to the prefrontal cortex, is a key mechanism underlying the characteristic cognitive profile of LBD (Cummings, 1986; Bonelli & Cummings, 2007). These circuits are crucial for executive functions, including planning, set-shifting, and problem-solving, which are prominently impaired in DLB and PDD (Levy & Chelune, 2007; Poletti et al., 2012). The cognitive slowing (bradyphrenia) and attentional deficits seen in LBD are also attributed to this fronto-striatal dysfunction (Cummings, 1986; Emre, 2003).

In contrast to Alzheimer's disease (AD), which is characterized by severe, early atrophy of medial temporal lobe structures like the hippocampus, structural neuroimaging in DLB often shows relative preservation of these regions, particularly in the early stages (Derouesné, 2006; Burns, 2000). This relative sparing of the hippocampus correlates with the clinical observation that episodic memory deficits, while present, are often less severe in early DLB compared to early AD, with retrieval deficits being more prominent than encoding or storage failures (Levy & Chelune, 2007; Boeve, 2004; Ferman et al., 2002). Some studies, however, do report hippocampal atrophy in DLB, which may be related to co-occurring AD pathology (Nedelská et al., 2019; Sánchez Castañeda, 2009). One structural finding that may be more specific to DLB is diminished volume or atrophy of the insula (Blanc & Verny, 2017).

Functional connectivity studies using electroencephalography (EEG) have identified alterations in brain networks that correlate with clinical symptoms. In DLB, there is often a characteristic EEG pattern of diffuse slowing of the background rhythm, with a shift of the dominant posterior rhythm from the alpha to the theta range, and the presence of frontal intermittent rhythmic delta activity (FIRDA) (Derouesné, 2006; Gouw & Stam, 2016; Jellinger, 2024). Recent analyses of resting-state EEG networks have shown decreased activity in occipital visual and sensorimotor networks in DLB patients compared to controls (Aoki et al., 2019). Decreased occipital alpha activity has been correlated with impairments in attention, visuospatial function, and global cognition, providing a neurophysiological substrate for these core deficits (Aoki et al., 2019).

#### Neuroimaging Findings

Neuroimaging plays a crucial role in the differential diagnosis of DLB, helping to distinguish it from AD and other parkinsonian syndromes (Geser et al., 2005). While conventional MRI may be unremarkable or show only generalized atrophy in early DLB, certain functional and molecular imaging techniques provide more specific biomarkers (Derouesné, 2006; Blanc & Verny, 2017).

Dopamine transporter single-photon emission computed tomography (DAT-SPECT) is a key supportive biomarker for DLB (Derouesné, 2006; Geser et al., 2005). This imaging modality measures the integrity of presynaptic dopaminergic nerve terminals in the striatum. In DLB and PD, there is a characteristic reduction in dopamine transporter uptake, reflecting the underlying nigrostriatal degeneration (Arnaldi et al., 2012; Teune & Leenders, 2012). This finding is typically absent in AD, frontotemporal dementia, and drug-induced parkinsonism, making it a highly specific tool for differentiating LBD from these conditions (McKeith et al., 2017 as cited by Wyman-Chick et al., 2024; Geser et al., 2005).

Functional neuroimaging with [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) or perfusion SPECT reveals patterns of cerebral metabolism or blood flow. While AD is typically associated with hypometabolism/hypoperfusion in the temporoparietal regions and precuneus, DLB often shows a distinct pattern of hypometabolism/hypoperfusion in the occipital cortex, particularly the primary visual cortex (Derouesné, 2006; Arnaldi et al., 2012; Peller et al., 2011). This occipital hypofunction is thought to be a neural correlate of the recurrent visual hallucinations and visuospatial deficits characteristic of DLB (Arnaldi et al., 2012; Trošt et al., 2019). However, some DLB patients may show patterns more typical of FTLD or AD, reflecting the heterogeneity of the disease (Banerjee et al., 2023).

Another highly valuable biomarker is cardiac sympathetic denervation, which can be visualized using [123I]-metaiodobenzylguanidine (MIBG) myocardial scintigraphy (Gaig et al., 2011; Donaghy & McKeith, 2014). MIBG is an analog of norepinephrine and its uptake in the myocardium reflects the integrity of postganglionic sympathetic cardiac nerves. Patients with LBD (both DLB and PD) typically show markedly reduced cardiac MIBG uptake, indicating severe cardiac sympathetic denervation (Gaig et al., 2011; Donaghy & McKeith, 2014). This finding is generally absent in AD, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and MSA, providing a powerful tool for differential diagnosis (McKeith et al., 2017 as cited by Wyman-Chick et al., 2024; Gaig et al., 2011). This peripheral autonomic denervation is a manifestation of the widespread nature of Lewy pathology, which affects the peripheral autonomic nervous system early in the disease course (Donaghy & McKeith, 2014).

### Developmental Neurobiology

Lewy body disease is classically considered an age-related neurodegenerative disorder, with clinical onset typically occurring in late life (McKeith, 2000; Hindle, 2010). However, a growing body of evidence from clinical, pathological, and imaging studies indicates that the underlying neurobiological process begins decades before the emergence of the cardinal motor and cognitive syndromes (Savica et al., 2010; Claassen et al., 2010; Postuma et al., 2012). This extended "prodromal" or "preclinical" phase suggests that LBD is not an acute event of aging but rather a slow, progressive neurodevelopmental failure in the adult brain, where pathological changes accumulate over a long period before crossing a clinical threshold (Donaghy & McKeith, 2014; Morales‐Briceño et al., 2011).

The earliest stages of Lewy pathology, according to the Braak staging hypothesis, are thought to occur in the peripheral autonomic nervous system, the lower brainstem (dorsal motor nucleus of the vagus), and the olfactory bulb (Saito & Murayama, 2012; Braak et al., 2003 as cited by Postuma et al., 2012). This anatomical staging provides a neurobiological basis for the observation that a constellation of non-motor symptoms frequently precedes the diagnosis of PD or DLB by many years, and sometimes by several decades (Savica et al., 2010; Postuma et al., 2012; Claassen et al., 2010).

One of the most specific and well-studied prodromal markers is REM sleep behavior disorder (RBD) (Verghese, 2000; St. Louis et al., 2017). RBD is a parasomnia characterized by the loss of normal muscle atonia during REM sleep, leading to dream-enacting behaviors that can be complex and violent (Schenck, 1987; Howell, 2020). The neurodegeneration of brainstem nuclei responsible for REM atonia, particularly the sublaterodorsal nucleus in the pons, is believed to be the core pathophysiological mechanism (McKenna & Peever, 2017; St. Louis et al., 2017). Longitudinal studies have shown that the vast majority of individuals with idiopathic RBD (iRBD)—that is, RBD without a concurrent neurological diagnosis—will eventually develop a clinical synucleinopathy, most commonly PD, DLB, or MSA (Claassen et al., 2010; Ferini‐Strambi et al., 2015; Postuma et al., 2012; Schenck, 1987). The latency between RBD onset and the diagnosis of a motor or cognitive syndrome can be extensive, ranging from years to as long as 50 years, with a median of 25 years in one long-term study (Claassen et al., 2010). This makes iRBD one of the strongest known clinical predictors of future synucleinopathy (Donaghy & McKeith, 2014; St. Louis, 2019). The presentation of dementia and RBD, even without parkinsonism or hallucinations, is highly suggestive of underlying Lewy body disease (Ferman et al., 2002).

Other non-motor symptoms also serve as early indicators of this protracted neurodevelopmental decline. Olfactory dysfunction (hyposmia) is present in over 90% of patients with early PD and is considered one of the earliest signs of the disease, often preceding motor symptoms (Doty & Tekelı, 2012; Donaghy & McKeith, 2014). This deficit is linked to the early involvement of the olfactory bulb and anterior olfactory nucleus by Lewy pathology (Saito & Murayama, 2012; Doty & Tekelı, 2012). Similarly, chronic constipation, resulting from α-synuclein deposition in the enteric nervous system, is a frequent and very early feature of the prodromal phase (Donaghy & McKeith, 2014; Postuma et al., 2012). Autonomic symptoms such as orthostatic hypotension and urinary dysfunction can also appear years before the classic motor and cognitive syndromes are diagnosed (Donaghy & McKeith, 2014; McKay & Cheshire, 2018).

Neuropsychiatric symptoms, including depression and anxiety, are also common in the prodromal phase (Stella et al., 2014; Donaghy & McKeith, 2014; Savica et al., 2010). These mood disorders may represent an early manifestation of the neurodegenerative process itself, potentially linked to early disruption of serotonergic and noradrenergic pathways originating in the brainstem raphe nuclei and locus coeruleus, respectively (Pérez-Lloret & Barrantes, 2016; Savica et al., 2010). The presence of these non-motor symptoms in various combinations can help identify individuals in a prodromal state of LBD, offering a critical window for potential neuroprotective interventions before widespread and irreversible neuronal loss occurs (Donaghy & McKeith, 2014; Postuma et al., 2012; Blanc & Verny, 2017). The recognition of this long prodromal phase has shifted the conceptualization of LBD from a disease of old age to a lifelong process with late clinical expression.

### Treatment Mechanisms

Currently, there are no curative or disease-modifying therapies for Lewy body disease; management is entirely symptomatic and focuses on alleviating the diverse motor, cognitive, and psychiatric manifestations of the disorder (Mosimann & McKeith, 2003; Gold, 2009). The biological basis for current treatments lies in targeting the specific neurotransmitter systems that are most profoundly affected by the underlying α-synuclein pathology.

The severe cortical cholinergic deficit is a primary target for pharmacological intervention (Emre, 2003; Perry et al., 1990). Cholinesterase inhibitors, such as rivastigmine and donepezil, work by increasing the synaptic availability of acetylcholine by inhibiting its breakdown by acetylcholinesterase (Hanağası et al., 2016; Arnaldi et al., 2012). These medications have demonstrated efficacy in randomized controlled trials for treating the cognitive and neuropsychiatric symptoms of PDD and, to some extent, DLB (Hanağası et al., 2016; Seppi & Rascol, 2007). They can lead to modest improvements in global function, cognition (particularly attention and executive function), and behavioral disturbances, including apathy, anxiety, delusions, and hallucinations (Rojas‐Fernandez & MacKnight, 1999; Mosimann & McKeith, 2003; Gold, 2009; Sezgi̇n et al., 2019). The positive effect on visual hallucinations is particularly notable and may be linked to the restoration of cholinergic modulation in visual processing pathways (Perry et al., 1990; Reimers et al., 2014).

Management of the parkinsonian motor syndrome is based on augmenting dopaminergic neurotransmission to compensate for the loss of nigrostriatal neurons (Jankovic, 2008; Mizuno, 1997). Levodopa, a dopamine precursor, remains the most effective treatment for the motor symptoms of LBD (Mayo & Bordelon, 2014; Sethi, 2002). However, its use is often limited by a higher risk of exacerbating or inducing psychotic symptoms, particularly visual hallucinations and delusions, compared to its use in idiopathic PD (Factor et al., 1995; Fénelon, 2006). This adverse effect is thought to result from the stimulation of hypersensitive mesolimbic dopamine receptors in the context of widespread cortical pathology (Factor et al., 1995; Galasko, 1999). Therefore, a "start low, go slow" approach is recommended, using the lowest effective dose to balance motor benefit against psychiatric side effects (Derouesné, 2006; Galasko, 1999). Dopamine agonists may also be used but often carry an even higher risk of psychosis (Factor et al., 1995).

The treatment of psychotic symptoms presents a major challenge due to the high risk of severe neuroleptic sensitivity (Mosimann & McKeith, 2003; Stancu et al., 2024). When non-pharmacological approaches fail and symptoms are severe, low-dose atypical antipsychotics with minimal D2 receptor antagonism, such as quetiapine or clozapine, are the agents of choice (Prakash et al., 2009; Fénelon, 2006; Ercika et al., 2025). These drugs have a lower propensity to worsen parkinsonism compared to typical antipsychotics (Factor et al., 1995). The mechanism of action is thought to involve a higher ratio of serotonin (5-HT2A) to dopamine (D2) receptor blockade, which may help alleviate psychosis without severely impacting motor function (Factor et al., 1995).

REM sleep behavior disorder (RBD) is managed based on its presumed neurobiological underpinnings in the brainstem. Clonazepam, a benzodiazepine, is often effective and is thought to work by enhancing GABAergic inhibition, thereby helping to restore muscle atonia during REM sleep (Schenck, 1987; Howell, 2020). Melatonin is another first-line treatment, which may help regulate circadian rhythms and has also been shown to be effective in controlling the motor behaviors of RBD, though its exact mechanism is not fully understood (Howell, 2020; St. Louis et al., 2017).

Finally, addressing autonomic dysfunction is a critical component of management. Orthostatic hypotension, a frequent and disabling symptom, is managed with non-pharmacological measures (e.g., increased salt and fluid intake, compression stockings) and pharmacological agents like fludrocortisone or midodrine, which aim to increase blood volume or peripheral vascular resistance (Kaufmann & Biaggioni, 2003; Mathias & Low, 2020). The biological basis of these interventions is to compensate for the loss of sympathetic nervous system integrity that characterizes LBD (Kaufmann & Biaggioni, 2003). The overall treatment strategy for LBD is thus a multimodal, symptomatic approach that requires careful balancing of therapeutic benefits and potential adverse effects across multiple affected neurobiological systems.

### Future Directions

The field of Lewy body disease research is rapidly advancing, yet many critical questions about its underlying biology and clinical management remain unanswered. Future research must focus on several key areas to improve diagnosis, develop effective treatments, and enhance patient care.

A primary goal is the development and validation of more sensitive and specific biomarkers for the early and accurate diagnosis of LBD, particularly in its prodromal stages (Donaghy & McKeith, 2014; Jellinger, 2024). While DAT-SPECT and MIBG scintigraphy are valuable tools, they are not universally available or definitive (Geser et al., 2005; Gaig et al., 2011). There is an urgent need for accessible and reliable fluid and tissue biomarkers. Research into α-synuclein seed amplification assays (SAAs) in cerebrospinal fluid and skin biopsies is highly promising for the direct detection of the core pathology (Stefani et al., 2025; Wyman-Chick et al., 2024). Longitudinal studies are essential to validate these markers and determine their predictive value for disease progression and conversion from prodromal states like iRBD to clinical dementia or parkinsonism (Verghese, 2000; Jellinger, 2024).

Elucidating the complex pathobiological mechanisms of LBD is another critical frontier. This includes understanding the triggers for α-synuclein misfolding and aggregation, the mechanisms of its prion-like cell-to-cell propagation, and the specific factors that confer selective neuronal vulnerability (Giubilei & Orzi, 2014; Yang et al., 2022; Jellinger, 2024). Further investigation is needed to unravel the intricate interactions between α-synuclein, tau, and amyloid-β pathologies, as their co-occurrence significantly impacts the clinical phenotype and disease trajectory (Galpern & Lang, 2006; Dickson & Orr, 2011). Understanding these molecular-level interactions is fundamental to designing therapies that can target the root cause of neurodegeneration.

The heterogeneity of LBD presents a major challenge. Future research should aim to define distinct biological subtypes of the disease based on genetic profiles, patterns of pathological spread, and dominant neurotransmitter deficits (Kon et al., 2019; Jellinger, 2024). Such a stratification could lead to more personalized medicine, allowing for the selection of treatments tailored to a patient's specific underlying neurobiology. Well-designed longitudinal clinico-pathological studies are warranted to clarify the alterations leading to different cognitive and motor phenotypes (Jellinger, 2024).

Ultimately, the most pressing need is for the development of disease-modifying therapies that can slow, halt, or even prevent the neurodegenerative process. Current therapeutic strategies are purely symptomatic (Mosimann & McKeith, 2003). Future directions include immunotherapies targeting α-synuclein (antibodies or vaccines), agents that inhibit its aggregation, and strategies to enhance its clearance through mechanisms like the ubiquitin-proteasome system or lysosomal autophagy (Stefani et al., 2025). The identification of individuals in the prodromal phase of LBD, through markers like RBD, provides a unique opportunity to test these neuroprotective strategies at a very early stage, before substantial and irreversible neuronal loss has occurred (Donaghy & McKeith, 2014; St. Louis, 2019; Ferini‐Strambi et al., 2015).

Finally, more large-scale, randomized controlled trials are needed to establish evidence-based guidelines for the symptomatic management of the myriad non-motor symptoms of LBD, including autonomic dysfunction, sleep disorders, and the full spectrum of neuropsychiatric features (Aarsland & Ehrt, 2003; Stancu et al., 2024). Addressing these debilitating symptoms is crucial for improving the quality of life for both patients and their caregivers as the field moves toward an era of more precise diagnostics and targeted therapeutics.

### Conclusion

Lewy body disease stands as a complex and formidable neurodegenerative condition, second only to Alzheimer's disease in its prevalence as a cause of dementia. Its biological underpinnings are rooted in the pathological aggregation of α-synuclein, which forms the Lewy bodies and Lewy neurites that define the disorder and disrupt neuronal function across a wide expanse of the nervous system (Pavlović & Pavlović, 2004; Goedert et al., 2003). This widespread pathology, extending from the brainstem and peripheral autonomic nerves to the limbic system and neocortex, gives rise to the disease's characteristic and heterogeneous clinical phenotype, which encompasses a devastating combination of cognitive decline, parkinsonism, psychosis, sleep disorders, and autonomic failure (McKeith, 2000; Knopman, 2017).

The neurobiology of LBD is distinguished by a profound and dual deficit in both the cholinergic and dopaminergic systems, a neurochemical signature that explains many of its core symptoms and provides the rationale for current symptomatic therapies (Emre, 2003; Hanağası et al., 2016). The severe cortical cholinergic deficiency contributes significantly to the fluctuating attention, cognitive impairment, and visual hallucinations, while the loss of nigrostriatal dopamine drives the parkinsonian motor features (Perry et al., 1990; Jankovic, 2008). This complex neurochemical imbalance also underlies the therapeutic challenges unique to LBD, such as the exacerbation of psychosis with dopaminergic agents and the severe sensitivity to neuroleptics (Factor et al., 1995; Mosimann & McKeith, 2003).

Neuroimaging and other biomarkers have provided invaluable windows into the living brain, revealing characteristic patterns of reduced dopamine transporter uptake, occipital hypometabolism, and cardiac sympathetic denervation that aid in the difficult task of differential diagnosis (Geser et al., 2005; Arnaldi et al., 2012). Furthermore, the recognition of a long prodromal phase, often heralded by symptoms such as REM sleep behavior disorder and olfactory dysfunction, has fundamentally reshaped our understanding of LBD's natural history (Donaghy & McKeith, 2014; Claassen et al., 2010). This knowledge underscores that LBD is a slowly progressive process that begins decades before a clinical diagnosis is possible, offering a crucial, albeit challenging, window for future neuroprotective interventions.

Despite significant advances, the precise molecular triggers for α-synucleinopathy, the mechanisms of its prion-like spread, and its complex interplay with co-pathologies like Alzheimer's disease remain areas of intense investigation (Giubilei & Orzi, 2014; Dickson & Orr, 2011). The journey from understanding the fundamental biology of Lewy bodies to developing therapies that can halt the devastating progression of the disease is ongoing. However, the integrated knowledge from neuropathology, neurochemistry, genetics, and clinical neuroscience has provided a solid foundation upon which to build future diagnostic and therapeutic strategies, offering hope for the millions affected by this disease.

### References
Aarsland, D., & Ehrt, U. (2003). Basal ganglia diseases and geriatric psychiatry: a new approach. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200311000-00004
Aoki, Y., Kazui, H., Pascal-Marqui, R. D., Ishii, R., Yoshiyama, K., Kanemoto, H., Suzuki, Y., Sato, S., Hata, M., Canuet, L., Iwase, M., & Ikeda, M. (2019). EEG Resting-State Networks in Dementia with Lewy Bodies Associated with Clinical Symptoms. Neuropsychobiology. https://doi.org/10.1159/000495620
Arnaldi, D., Morbelli, S., Morrone, E., Campus, C., & Nobili, F. (2012). Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.. PubMed.
Assal, F., & Cummings, J. L. (2002). Neuropsychiatric symptoms in the dementias. Current Opinion in Neurology. https://doi.org/10.1097/00019052-200208000-00007
Banerjee, N., Hicks, C., & Acosta, L. M. Y. (2023). A - 40 Assessment of Dementia with Lewy Bodies in a Patient with both Characteristic and Atypical Features. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acad067.057
Beccari, T., Michiara, M., Paciotti, S., Persichetti, E., Chiasserini, D., Castrioto, A., Tambasco, N., Rossi, A., Calabresi, P., Pagliardini, V., Bembi, B., & Parnetti, L. (2011). Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease. InTech eBooks. https://doi.org/10.5772/23552
Bencze, J., Simon, V., Bereczki, E., Majer, R., Varkoly, G., Murnyák, B., Kálmán, J., & Hortobágyi, T. (2017). A Lewy-testes demencia klinikai és neuropatológiai jellemzői | Clinical and neuropathological characteristics of dementia with Lewy bodies.
Blanc, F., & Verny, M. (2017). Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0675
Boeve, B. F. (2004). Asymmetric cortical degeneration syndrome: semantic dementia. https://doi.org/10.1093/oso/9780195177442.003.0001
Bohnen, N. I., & Shulman, J. (2019). Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-191627
Bonelli, R. M., & Cummings, J. L. (2007). Frontal-subcortical circuitry and behavior. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2007.9.2/rbonelli
Burn, D. J., & Yarnall, A. J. (2015). Motor symptoms and phenotype in patients with Parkinson’s disease dementia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199681648.003.0007
Burns, A. (2000). Diagnosis and management of Alzheimer's disease. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2000.2.2/aburns
Candela, S. F., Giubilei, F., & Orzi, F. (2013). Heterogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism.. PubMed.
Claassen, D. O., Josephs, K. A., Ahlskog, J. E., Silber, M. H., Tippmann‐Peikert, M., & Boeve, B. F. (2010). REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. https://doi.org/10.1212/wnl.0b013e3181ec7fac
Cummings, J. L. (1986). Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.149.6.682
Derouesné, C. (2006). Dementia with Lewy bodies: third report of DLB consortium. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
Dickson, D. W., & Orr, C. (2011). Neuropathology of Dementia in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch14
Donaghy, P. C., & McKeith, I. G. (2014). The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimer s Research & Therapy. https://doi.org/10.1186/alzrt274
Doty, R. L., & Tekelı, H. (2012). Chapter 9. Olfactory function in Parkinson’s disease. Advances in consciousness research. https://doi.org/10.1075/aicr.85.16dot
Emre, M. (2003). What causes mental dysfunction in Parkinson's disease?. Movement Disorders. https://doi.org/10.1002/mds.10565
Ercika, L., & Taube, M. (2025). Case Report: Lewy body dementia with unusual psychotic symptoms, atypically late parkinsonism, and patient sensitivity to first generation antipsychotics. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1551581
Factor, S. A., Molho, E., Podskalny, G. D., & Brown, D. (1995). Parkinson's disease: drug-induced psychiatric states.. PubMed.
Fénelon, G. (2006). [Psychotic symptoms in Parkinson's disease].. PubMed.
Ferman, T. J., Boeve, B. F., Smith, G. E., Silber, M. H., Lucas, J. A., Graff‐Radford, N. R., Dickson, D. W., Parisi, J. E., Petersen, R. C., & Ivnik, R. J. (2002). Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617702870047
Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015). REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039822014238
Gaig, C., Valldeoriola, F., Gelpí, E., Ezquerra, M., Llufriú, S., Buongiorno, M., Rey, M., Martı́, M. J., Graus, F., & Tolosa, E. (2011). Rapidly progressive diffuse Lewy body disease. Movement Disorders. https://doi.org/10.1002/mds.23506
Galasko, D. (1999). A CLINICAL APPROACH TO DEMENTIA WITH LEWY BODIES. The Neurologist. https://doi.org/10.1097/00002893-199909000-00002
Galpern, W. R., & Lang, A. E. (2006). Interface between tauopathies and synucleinopathies: A tale of two proteins. Annals of Neurology. https://doi.org/10.1002/ana.20819
Geser, F., Wenning, G. K., Poewe, W., & McKeith, I. G. (2005). How to diagnose dementia with Lewy bodies: State of the art. Movement Disorders. https://doi.org/10.1002/mds.20535
Gibb, W. R., Luthert, P. J., Janota, I., & Lantos, P. L. (1989). Cortical Lewy body dementia: clinical features and classification.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.52.2.185
Giubilei, F., & Orzi, F. (2014). Hetrogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039829201344
Goedert, M., Jakes, R., Crowther, R. A., & Spillantini, M. G. (2003). Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy as α-Synucleinopathies. Parkinson s Disease. https://doi.org/10.1385/1-59259-142-6:33
Gold, G. E. (2009). Dementia with Lewy Bodies: Clinical Diagnosis and Therapeutic Approach. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. https://doi.org/10.1159/000197889
Gouw, A., & Stam, C. J. (2016). Electroencephalography in the differential diagnosis of dementia.
Hanağası, H., Bılgıç, B., & Emre, M. (2016). Dementia with Lewy bodies and Parkinson’s disease dementia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199655946.003.0036
Hindle, J. V. (2010). Ageing, neurodegeneration and Parkinson's disease. Age and Ageing. https://doi.org/10.1093/ageing/afp223
Hornykiewicz, O., & Kish, S. J. (1984). Neurochemical Basis of Dementia in Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100046382
Howell, M. J. (2020). Rapid Eye Movement Sleep Behavior Disorder and Other Rapid Eye Movement Parasomnias. CONTINUUM Lifelong Learning in Neurology. https://doi.org/10.1212/con.0000000000000896
Ince, P. G. (2011). Dementia with Lewy Bodies and Parkinson's Disease Dementia. https://doi.org/10.1002/9781444341256.ch22
Ishikawa, A. (1997). [Diffuse Lewy body disease].. PubMed.
Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2007.131045
Jellinger, K. A. (2000). Morphological substrates of mental dysfunction in Lewy body disease: an update. https://doi.org/10.1007/978-3-7091-6781-6_21
Jellinger, K. A. (2024). Mild cognitive impairment in Parkinson's disease: current view. Frontiers in Cognition. https://doi.org/10.3389/fcogn.2024.1369538
Johnson, M., Shafi, N., Parker, J. C., & Parker (2005). Dementia with Lewy bodies: a commonly unrecognized cause of dementia..
Kaufmann, H., & Biaggioni, I. (2003). Autonomic Failure in Neurodegenerative Disorders. Seminars in Neurology. https://doi.org/10.1055/s-2004-817719
Kempster, P., Williams, D. R., Selikhova, M., Holton, J., Révész, T., & Lees, A. J. (2007). Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain. https://doi.org/10.1093/brain/awm142
Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. https://doi.org/10.2310/neuro.1336
Kon, T., Tomiyama, M., & Wakabayashi, K. (2019). Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases. Neuropathology. https://doi.org/10.1111/neup.12597
Levy, J. A., & Chelune, G. J. (2007). Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988707308806
Londos, E., Hansson, O., Rosén, I., & Englund, E. (2019). Extreme sleep pattern in Lewy body dementia: a hypothalamic matter?. BMJ Case Reports. https://doi.org/10.1136/bcr-2018-228177
Mathias, C. J., & Low, D. A. (2020). Diseases of the autonomic nervous system. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0603
Mayo, M., & Bordelon, Y. (2014). Dementia with Lewy Bodies. Seminars in Neurology. https://doi.org/10.1055/s-0034-1381741
McKay, J. H., & Cheshire, W. P. (2018). First symptoms in multiple system atrophy. Clinical Autonomic Research. https://doi.org/10.1007/s10286-017-0500-0
McKeith, I. G. (2000). Clinical Lewy Body Syndromes. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2000.tb06898.x
McKenna, D., & Peever, J. (2017). Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder. Movement Disorders. https://doi.org/10.1002/mds.27003
Mendez, M. F. (2001). Emergent Neuroleptic Hypersensitivity as a Herald of Presenile Dementia. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.13.3.347
Mizuno, Y. (1997). [Concept and diagnostic criteria of Parkinson's disease and parkinsonism].. PubMed.
Mollenhauer, B., & Weintraub, D. (2017). The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1700737114
Morales‐Briceño, H., Cervantes‐Arriaga, A., & Rodríguez‐Violante, M. (2011). [Premotor diagnosis of Parkinson's disease].. Gaceta Médica de México.
Mosimann, U. P., & McKeith, I. G. (2003). Dementia with lewy bodies - diagnosis and treatment. Schweizerische medizinische Wochenschrift. https://doi.org/10.4414/smw.2003.10028
Nedelská, Z., Boeve, B. F., Ferman, T. J., Senjem, M. L., Przybelski, S. A., Lesnick, T. G., Knopman, D. S., Graff‐Radford, J., Jones, D. T., Savica, R., Drubach, D. A., Fields, J. A., Graff‐Radford, N. R., Lowe, V. J., Jack, C. R., Petersen, R. C., & Kantarci, K. (2019). P3‐427: MILD COGNITIVE IMPAIRMENT PROGRESSING TO DEMENTIA WITH LEWY BODIES: REGIONAL ATROPHY RATES AND RELATIONSHIP TO AV‐1451 UPTAKE. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2019.06.3461
Pavlović, D., & Pavlović, A. (2004). Lewy body dementia: Literature review and a case study. Psihijatrija danas.
Peller, P. J., Hunt, C. H., & Johnson, G. B. (2011). FDG PET/CT brain imaging in atypical parkinsonian disorders: A pictorial guide with MRI correlation.
Perry, E. K., Kerwin, J., Perry, R. H., Irving, D., Blessed, G., & Fairbairn, A. (1990). Cerebral Cholinergic Activity Is Related to the Incidence of Visual Hallucinations in Senile Dementia of Lewy Body Type. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000107114
Pérez-Lloret, S., & Barrantes, F. J. (2016). Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. npj Parkinson s Disease. https://doi.org/10.1038/npjparkd.2016.1
Poletti, M., Frosini, D., Pagni, C., Baldacci, F., Giuntini, M., Mazzucchi, S., Tognoni, G., Lucetti, C., Dotto, P. D., Ceravolo, R., & Bonuccelli, U. (2012). The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve (de novo) PD patients. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2012.751966
Postuma, R. B., Aarsland, D., Barone, P., Burn, D. J., Hawkes, C. H., Oertel, W. H., & Ziemssen, T. (2012). Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.24996
Prakash, R., Pathak, A., Munda, S. K., & Bagati, D. (2009). Quetiapine Effective in Treatment of Inappropriate Sexual Behavior of Lewy Body Disease With Predominant Frontal Lobe Signs. American Journal of Alzheimer s Disease & Other Dementias®. https://doi.org/10.1177/1533317508329479
Reimers

## References

1. Aarsland, D., & Ehrt, U. (2003). Basal ganglia diseases and geriatric psychiatry: a new approach. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200311000-00004
2. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
3. Abreu, J. P., & Lucas, R. F. (2012). P-450 - Inaugural psychiatric presentation of sporadic Creutzfeldt-Jacob disease: case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)74617-5
4. Acheson, J., Bremner, F., Ajina, S., Plant, G., Howard, R., Leff, A., & Toosy, A. (2024). Neuro‐Ophthalmology. Neurology. https://doi.org/10.1002/9781119715672.ch22
5. Adebayo, K., Gureje, O., & Nuhu, T. (2012). Obsessive-compulsive Disorder: A Spectrum or Prodrome of Schizophrenia? A Case Report and Literature Review.. Deleted Journal.
6. Adler, G. (2006). Diagnostik der Demenz. Notfall & Hausarztmedizin (Notfallmedizin). https://doi.org/10.1055/s-2006-959110
7. Akçakuş, M., Güneş, T., Kumandaş, S., Kurtoğlu, S., & Çoşkun, A. (2003). Joubert syndrome: Report of a neonatal case. Paediatrics & Child Health. https://doi.org/10.1093/pch/8.8.499
8. Al-Mosawi, A. (2019). Facial Dysmorphism, Mental Retardation, Triphalangeal Toes and Unilateral Renal Agenesis: A New Syndrome. International Invention of Scientific Journal.
9. Alarcón, A., Carreras, N., Muehlbacher, T., Casas‐Alba, D., Arena, R., Roca‐Llabrés, P., Navarro‐Morón, J., Vries, L. S. D., & Govaert, P. (2025). Foetal disruptive brain injuries: Diagnosing the underlying pathogenetic mechanisms with cranial ultrasonography. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.16380
10. Albano, A. M., & Silverman, W. K. (2024). Bipolar Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0017
11. Albrecht, B., Sandersleben, H. U.-V., Gevensleben, H., & Rothenberger, A. (2015). Pathophysiology of ADHD and associated problems—starting points for NF interventions?. Frontiers in Human Neuroscience. https://doi.org/10.3389/fnhum.2015.00359
12. Alluri, P. R., Solit, J., Leveroni, C. L., Goldberg, K. J., Vehar, J. V., Pollak, L., Colvin, M. K., & Perez, D. L. (2020). Cognitive Complaints in Motor Functional Neurological (Conversion) Disorders: A Focused Review and Clinical Perspective. Cognitive and Behavioral Neurology. https://doi.org/10.1097/wnn.0000000000000218
13. Amanat, M., Vaccaro, A. R., Salehi, M., & Rahimi‐Movaghar, V. (2019). Neurological conditions associated with spinal cord injury. Informatics in Medicine Unlocked. https://doi.org/10.1016/j.imu.2019.100245
14. Amidi, A., Ancoli-Israel, S., Maglione, J. E., & Wu, L. M. (2025). Sleep Disorders in the Elderly. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780197602751.013.27
15. Amihăesei, I. C., & Mungiu, O. C. (2013). Main neuroendocrine features and therapy in primary sleep troubles.. PubMed.
16. Amores, F. B. C., Pérez, G. P. L., Torres, N. A. C., & Carpio, V. D. P. C. (2023). Sleep pattern impairment in nursing students according to NANDA. Medwave. https://doi.org/10.5867/medwave.2023.s1.uta111
17. Anderson, K. N., Shneerson, J. M., & Smith, I. (2007). CORRECTION. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2006.109058corr1
18. Andrade, D. M., Campo, J. M. D., Moro, E., Minassian, B. A., & Wennberg, R. (2005). Nonepileptic visual hallucinations in Lafora disease. Neurology. https://doi.org/10.1212/01.wnl.0000156907.49247.05
19. Andrews, G., Stewart, G., Morris‐Yates, A., Holt, P. E., & Henderson, S. (1990). Evidence for a General Neurotic Syndrome. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.157.1.6
20. Anwar, Z., Yaqoob, J., El‐Morshedy, S., & Al-Saadi, M. (2017). Lissencephaly and nephrotic syndrome: Galloway-Mowat syndrome. Journal of Clinical Neonatology. https://doi.org/10.4103/jcn.jcn_128_16
21. Aoki, Y., Kazui, H., Pascal-Marqui, R. D., Ishii, R., Yoshiyama, K., Kanemoto, H., Suzuki, Y., Sato, S., Hata, M., Canuet, L., Iwase, M., & Ikeda, M. (2019). EEG Resting-State Networks in Dementia with Lewy Bodies Associated with Clinical Symptoms. Neuropsychobiology. https://doi.org/10.1159/000495620
22. Arango, C., Fraguas, D., & Parellada, M. (2013). Differential Neurodevelopmental Trajectories in Patients With Early-Onset Bipolar and Schizophrenia Disorders. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbt198
23. Arango, C., Kirkpatrick, B., & Buchanan, R. W. (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
24. Arnaldi, D., Morbelli, S., Morrone, E., Campus, C., & Nobili, F. (2012). Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.. PubMed.
25. Arzimanoglou, A., & Cross, J. H. (2019). Cognitive impairment and behavioral disorders in Encephalopathy related to Status Epilepticus during slow Sleep: diagnostic assessment and outcome. Epileptic Disorders. https://doi.org/10.1684/epd.2019.1060
26. Assal, F., & Cummings, J. L. (2002). Neuropsychiatric symptoms in the dementias. Current Opinion in Neurology. https://doi.org/10.1097/00019052-200208000-00007
27. Auerbach, S. (2014). Sleep Disorders. https://doi.org/10.1002/9781118730676.ch13
28. Autor, J. L. M. C., & Principal, C. M. A. C. O. T. (2018). Demencia tipo Alzheimer vs pseudo demencia por depresión. Estudio neuropsicológico de un caso. XII CONGRESO DE POSGRADO EN PSICOLOGÍA | UNAM | 2018.
29. Autora, M. C. D. T., & Principal, C. I. Y. D. R. P. T. (2017). Funcionamiento cognitivo y alteraciones pragmáticas en pacientes con Esclerosis Múltiple.
30. Aydınli̇, N., Çalışkan, M., Özmen, M., & Tatlı, B. (2004). Non epileptik paroksismal olaylar: olgu sunumları ile derleme Derleme. Türk Pediatri Arşivi. https://doi.org/10.4274/tpa.v39i2.5000002421
31. Backer, W. D. (2006). Obstructive Sleep Apnea-Hypopnea Syndrome. KARGER eBooks. https://doi.org/10.1159/000093150
32. Bali, J., & Bali, O. (2024). A Practical Approach to Medically Unexplained Visual Loss. IntechOpen eBooks. https://doi.org/10.5772/intechopen.115222
33. Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., Isaacs, J. D., Larner, A. J., Nicholson, T. R., Pennington, C., Poole, N., Price, G., Price, J. P., Reuber, M., Ritchie, C., ... Carson, A. (2020). Functional cognitive disorder: dementia’s blind spot. Brain. https://doi.org/10.1093/brain/awaa224
34. Banerjee, N., Hicks, C., & Acosta, L. M. Y. (2023). A - 40 Assessment of Dementia with Lewy Bodies in a Patient with both Characteristic and Atypical Features. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acad067.057
35. Baran, A. S. (2003). Sleep Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.028
36. Barbosa, R., Postal, M., Costallat, L. T. L., Cendes, F., & Appenzeller, S. (2012). Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance. Current Rheumatology Reviews. https://doi.org/10.2174/157339712801318975
37. Barczak, A., Wańska, W., Sitek, E. J., Narożańska, E., Brockhuis, B., & Sławek, J. (2015). Otępienie z ciałami Lewy’ego — jak rozpoznawać?, jak leczyć?.
38. Bargiotas, P., & Bassetti, C. L. (2017). Sleep-related movement disorders and disturbances of motor control. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000000466
39. Barry, S., Baird, G., Lascelles, K., Bunton, P., & Hedderly, T. (2011). Neurodevelopmental movement disorders - an update on childhood motor stereotypies. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.04058.x
40. Basiri, K., & Rabani, G. (2007). Multiple Sclerosis Imitating As Conversion Reaction..
41. Bassetti, C. L., & Bargiotas, P. (2017). REM Sleep Behavior Disorder. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. https://doi.org/10.1159/000478914
42. Battaglia, D., Barone, M. R., Veredice, C., Waure, C. D., Ricci, D., Baranello, G., Mercuri, E., & Guzzetta, A. (2009). Early Development of Epileptic Infants with Pre- or Perinatal Brain Injuries: Role of the Epileptic Disorder. Neuropediatrics. https://doi.org/10.1055/s-0030-1248248
43. Beaumont, A., & Vespa, P. (2009). Seizures in Fulminant Hepatic Failure, Multiorgan Failure, and Endocrine Crisis. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-532-3_7
44. Beccari, T., Michiara, M., Paciotti, S., Persichetti, E., Chiasserini, D., Castrioto, A., Tambasco, N., Rossi, A., Calabresi, P., Pagliardini, V., Bembi, B., & Parnetti, L. (2011). Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease. InTech eBooks. https://doi.org/10.5772/23552
45. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
46. Begué, N. M., Cobos, E., Quiñones, S. M., & Ginebreda, J. A. (2011). Alteraciones morfologícas del disco óptico. Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears.
47. Bejenaru, A., & Ellison, J. M. (2020). Medicolegal Implications of Mild Neurocognitive Disorder. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988720957092
48. Belbachir, S., Moussaoui, N. E., Bahetta, S., Tbatou, L., & Ouanass, A. (2024). “Neuropsychiatric manifestation of hyponatremia: a case report”. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1332
49. Belen, A. C. A., Josue, R. D. A., Reyna, G. M. D., Alison, B. P. S., Valencia, B. S. S., Castro, H. R. C., Gabriela, V. F. K., & Stefania, V. Q. (2023). Revisión bibliográfica: repercusiones neurológicas y nefrológicas de la Eclampsia. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n1-203
50. Bellelli, G., Moresco, R., Panina–Bordignon, P., Arosio, B., Gelfi, C., Morandi, A., & Cesari, M. (2017). Is Delirium the Cognitive Harbinger of Frailty in Older Adults? A Review about the Existing Evidence. Frontiers in Medicine. https://doi.org/10.3389/fmed.2017.00188
51. Benaur, M., Burgut, F. T., & Henchcliffe, C. (2006). Late-life depression: a neuropsychiatric approach. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.1.65
52. Bencze, J., Simon, V., Bereczki, E., Majer, R., Varkoly, G., Murnyák, B., Kálmán, J., & Hortobágyi, T. (2017). A Lewy-testes demencia klinikai és neuropatológiai jellemzői | Clinical and neuropathological characteristics of dementia with Lewy bodies.
53. Beran-Koehn, M. A., Zupanc, M. L., Patterson, M. C., Olk, D. G., & Ahlskog, J. E. (2000). Violent recurrent ballism associated with infections in two children with static encephalopathy. Movement Disorders. https://doi.org/10.1002/1531-8257(200005)15:3<570::aid-mds1022>3.0.co;2-f
54. Besag, F. (2006). Cognitive and Behavioral Outcomes of Epileptic Syndromes: Implications for Education and Clinical Practice. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00709.x
55. Biabani, N., Mulas, M., Mutti, C., Higgins, S., Ilić, K., Benson, J., Santic, A., Gnoni, V., Drakatos, P., Romigi, A., Nesbitt, A., Naismith, S. L., Schenck, C. H., O’Regan, D., Puligheddu, M., & Rosenzweig, I. (2025). A non-neurodegenerative REM parasomnia with immersive dreaming and dream-reality confusion: a case report. Frontiers in Sleep. https://doi.org/10.3389/frsle.2025.1659300
56. Bird, S. J., & Rich, M. M. (2000). NEUROMUSCULAR COMPLICATIONS OF CRITICAL ILLNESS. The Neurologist. https://doi.org/10.1097/00127893-200006010-00002
57. Blanc, F., & Verny, M. (2017). Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0675
58. Blok, A., Verduyn, T. J., Vergouwen, A. C. M., & Weinstein, H. C. (2005). [Disorders of concentration and memory in young adults and middle-aged persons]..
59. Blythe, S. G., Beuret, L. J., Blythe, P., & Scaramella-Nowinski, V. (2017). The Effects of Neuromotor Immaturity in Adults and in Adolescents. https://doi.org/10.1002/9781119164746.ch9
60. Blythe, S. G., Beuret, L. J., Blythe, P., & Scaramella-Nowinski, V. (2017). The Significance of Primitive and Postural Reflexes. https://doi.org/10.1002/9781119164746.ch2
61. Boangiu, A. D., & Mihăilescu, G. (2016). None. Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2016.4
62. Boangiu, A. D., & Mihăilescu, G. (2016). VISUAL DISTURBANCES – A BORDERLINE BETWEEN OPHTHALMOLOGY AND NEUROLOGY. Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2016.4.1
63. Boeve, B. F. (2004). Asymmetric cortical degeneration syndrome: semantic dementia. https://doi.org/10.1093/oso/9780195177442.003.0001
64. Bohnen, N. I., & Shulman, J. (2019). Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-191627
65. Bon, O. L., Neu, D., Valente, F., & Linkowski, P. (2007). Paradoxical NREMS Distribution in “Pure” Chronic Fatigue Patients. Journal of Chronic Fatigue Syndrome. https://doi.org/10.1300/j092v14n02_05
66. Bonelli, R. M., & Cummings, J. L. (2007). Frontal-subcortical circuitry and behavior. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2007.9.2/rbonelli
67. Boon, P., Breuer, L. E. M., Grevers, E., Bernas, A., Bergmans, J., Besseling, R. M., Klooster, D., Louw, A. D., Mestrom, R., Vonck, K., Zinger, S., & Aldenkamp, A. P. (2016). Cognitive deterioration in adult epilepsy: clinical characteristics of “Accelerated Cognitive Ageing”. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.12700
68. Borrego, L. I. E., Mollineda, K. M., Guerra, V. M. C., & Guerra., E. C. (2018). Diagnóstico temprano de la Parálisis Supra Nuclear Progresiva.. Dilemas contemporáneos Educación Política y Valores.
69. Bransfield, R. C., & Friedman, K. J. (2019). Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses and Medical Uncertainty. Healthcare. https://doi.org/10.3390/healthcare7040114
70. Bravo, B., Portilla, N. O., González, S. M. B., Laynez, M. E. G., Urbanos, M. A., & Cortés, M. M. (2024). Cognitive impairment assessment in schizophrenia. purposely a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1572
71. Brems, H., Ravel, T. D., & Legius, E. (2010). Legius Syndrome and <scp> <i>SPRED</i> </scp> <i>1</i>. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0022475
72. Brody, D. L. (2014). Blurry Vision. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199383863.003.0020
73. Brody, D. L. (2014). Dizziness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199383863.003.0014
74. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
75. Broicher, S. D., & Jokeit, H. (2011). Emotional agnosis and theory of mind. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511977145.011
76. Bruin, V. M. S. D., Bittencourt, L., & Tufik, S. (2012). Sleep-Wake Disturbances in Parkinson’s Disease: Current Evidence regarding Diagnostic and Therapeutic Decisions. European Neurology. https://doi.org/10.1159/000335078
77. Brzecka, A., Leszek, J., Ashraf, G. M., Ejma, M., Ávila-Rodriguez, M., Yarla, N. S., Tarasov, V. V., Chubarev, V. N., Samsonova, A. N., Barreto, G. E., & Aliev, G. (2018). Sleep Disorders Associated With Alzheimer's Disease: A Perspective. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2018.00330
78. Brzecka, A., Madetko‐Alster, N., Nikolenko, V. N., Ashraf, G. M., Ejma, M., Leszek, J., Daroszewski, C., Sarul, K., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2020). Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link. Current Neuropharmacology. https://doi.org/10.2174/1570159x18666200309101750
79. Brás, J., Sousa, R. C. D., Costa, A. L., Melo, B., Marques, A., Teixeira, D., Pereira, C. A., & Cunha, N. (2019). A CASE OF NEUROLEPTIC MALIGNANT SYNDROME: A NEUROLOGIC EMERGENCY DUE TO PSYCHOTROPIC DRUGS. https://doi.org/10.26226/morressier.5d1a037357558b317a140392
80. Bs, P. K. (2009). [Sleep disorders and cognitive impairment: the cause and reaction].. PubMed.
81. Bttner-Teleaga, A. (2012). The Effects of Sleep-Related Breathing Disorders on Waking Performance. InTech eBooks. https://doi.org/10.5772/27868
82. Buchanan, B., Rossell, S. L., & Castle, D. (2011). Body dysmorphic disorder: a review of nosology, cognition and neurobiology. Neuropsychiatry. https://doi.org/10.2217/npy.10.3
83. Buinho, A., Soares, F. R., Oliveira, T., Fraga, M. E., & Facucho-Oliveira, J. (2025). Autoimmune Encephalitis - a diagnosis not to be overlooked in cases of psychosis. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2025.718
84. Buncic, J. R. (1999). Systemic and Pharmacological Effects on near Vision. American Orthoptic Journal. https://doi.org/10.1080/0065955x.1999.11982183
85. Burkojus, D., Gelžinienė, G., Pajėdienė, E., Stankevičienė, G., Misevičienė, V., & Jurkevičienė, G. (2025). Factors Affecting Sleep and Wakefulness in People with Epilepsy: A Narrative Review. Medicina. https://doi.org/10.3390/medicina61061000
86. Burn, D. J., & Yarnall, A. J. (2015). Motor symptoms and phenotype in patients with Parkinson’s disease dementia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199681648.003.0007
87. Burns, A. (2000). Diagnosis and management of Alzheimer's disease. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2000.2.2/aburns
88. Busby, C., & Burns, A. (2002). Differential Diagnosis of Dementia. https://doi.org/10.1002/0470846410.ch54
89. Caine, D., Halliday, G. M., JKril, J., & Harper, C. (1997). Operational criteria fortheclassification of chronic alcoholics: identification ofWemicke's encephalopathy.
90. Caixeta, L., & Vargas, C. M. (2013). Posterior cortical atrophy - a prototypical case of dementia beginning with visual symptoms: case report Atrofia cortical posterior - um caso prototípico de demência iniciando com sintomas visuais: relato de caso.
91. Caixeta, L., Taleb, A. C., Ghini, B. G., Soares, V. L. D., Caixeta, V. D. M., & Vargas, C. M. (2013). Posterior cortical atrophy - a prototypical case of dementia beginning with visual symptoms: case report. Arquivos Brasileiros de Oftalmologia. https://doi.org/10.1590/s0004-27492013000500014
92. Calcutt, N. A., & Freshwater, J. D. (2002). Animal models of toxic and metabolic sensory neuropathies. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-8129-6_8
93. Campistol, J. (2024). [Epilepsy or functional neurological disorder. Diagnostic strategies].. PubMed.
94. Candiri, B., Arıkan, A. N., & Çolak, S. C. (2023). Balance and Physical Activity in Children with Neurodevelopmental Disorders. Özgür Yayınları eBooks. https://doi.org/10.58830/ozgur.pub305.c1255
95. Canitano, R., & Pallagrosi, M. (2017). Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2017.00069
96. Carelli, V., & Morgia, C. L. (2017). Leber's hereditary optic neuropathy: the neurologist point of view. Acta Ophthalmologica. https://doi.org/10.1111/j.1755-3768.2017.02322
97. Caselli, R. J. (2000). Visual Syndromes as the Presenting Feature of Degenerative Brain Disease. Seminars in Neurology. https://doi.org/10.1055/s-2000-6839
98. Castañeda, C. S. (2009). Structural brain changes, cognitive deficits and visual hallucinations in dementia with lewy bodies and parkinson's disease with dementia. TDX (Tesis Doctorals en Xarxa).
99. Catolino, N. M., CAVALHEIRO, B. S., NAZIMA, K. M., BERNARDO, R. D. P., PUCPR, C. D. M. C., & Chu, B. B. R. (2019). SYSTEMIC LUPUS ERYTHEMATOSUS COMPLICATED BY CONVERSION DISORDER. Blucher Medical Proceedings. https://doi.org/10.5151/sbr2019-269
100. Cekić, S., Stanković-Babić, G., Višnjić, Z., Jovanović, I., & Risimić, D. (2010). Optic Disc Abnormalities – Diagnosis, Evolution and Influence on Visual Acuity. Bosnian Journal of Basic Medical Sciences. https://doi.org/10.17305/bjbms.2010.2711
101. Cerdas, M. T. G. (2018). Narcolepsia: abordaje diagnostico y terapeutico. Revista Medica Sinergia. https://doi.org/10.31434/rms.v3i12.161
102. Cervantes‐Arriaga, A., & Rodríguez‐Violante, M. (2011). Disfunción no motora en la enfermedad de Parkinson: una enfermedad neurológica con manifestaciones multisistémicas. Medicina Interna de México.
103. Chadha, Y., Toshniwal, S., & Patil, R. (2024). Diagnostic Dilemma: Unraveling Meige Disorder Mistaken for Functional Neurological Disorder. Cureus. https://doi.org/10.7759/cureus.61465
104. Chandra, A., & Pant, B. (2019). Hypophonia as only presenting symptom in myasthenia gravis – a diagnostic dilemma in poor countries: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/s13256-019-1970-6
105. Chang, Y., Han, I.-W., Na, H. R., & Kim, S.-Y. (2010). Encephalitis Lethargica With Catatonia. Journal of the Korean Neurological Association.
106. Charles, A. (2012). Migraine is not primarily a vascular disorder. Cephalalgia. https://doi.org/10.1177/0333102412441717
107. Chen, S.-H., Tsai, M., Tseng, Y., Tseng, Y., Lui, C., & Chuang, Y. (2010). Star fruit intoxication in a patient with moderate renal insufficiency presents as a posterior reversible encephalopathy syndrome.. PubMed.
108. Chen, W. X., Yang, S. D., Gao, Y., Ning, S. Y., Peng, B. W., Zhang, Y. N., Zhong, Y. Y., Zheng, K., & Ou, S. P. (2019). Landau Kleffner Syndrome: An Unusual Case With Progressive Ataxia Prior To Language Regression And Autistic-Like Behaviors. Neuropsychiatry. https://doi.org/10.4172/neuropsychiatry.1000553
109. Chen, Y., Garcia, G. E., Huang, W., & Constantini, S. (2014). The Involvement of Secondary Neuronal Damage in the Development of Neuropsychiatric Disorders Following Brain Insults. Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00022
110. Chhablani, P., & Kekunnaya, R. (2014). Neuro-ophthalmic manifestations of prematurity. Indian Journal of Ophthalmology. https://doi.org/10.4103/0301-4738.145990
111. Chicharro-Ciuffardi, A., González-Silva, M., Marinis-Palombo, A. D., & Gabler-Santalices, G. (2012). Psychiatric disorders secondary to nonconvulsive status epilepticus of frontal origin. Two clinical case reports.. PubMed.
112. Choi, M. S., & Kim, S.-Y. (2010). P3-110: Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2010.05.1607
113. Chopra, A., Bachu, R., & Peterson, M. J. (2020). Depressive Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190929671.003.0017
114. Chow, W., Khullar, A., Lalla, F., Lessard, S., Lowe, A., & McIntosh, D. (2025). Practical Recommendations for Hypnotic Switching in Insomnia Management: A Canadian Expert Clinical Framework. Canadian Primary Care Today. https://doi.org/10.58931/cpct.2025.3s0148
115. Chutorian, A. M. (2003). Pérdida aguda de visión en niños. Revista de Neurología. https://doi.org/10.33588/rn.3603.2002178
116. Cipriani, G., Lucetti, C., Danti, S., & Nuti, A. (2014). Sleep disturbances and dementia. Psychogeriatrics. https://doi.org/10.1111/psyg.12069
117. Claassen, D. O., Josephs, K. A., Ahlskog, J. E., Silber, M. H., Tippmann‐Peikert, M., & Boeve, B. F. (2010). REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. https://doi.org/10.1212/wnl.0b013e3181ec7fac
118. Clark, D. S., & Eggenberger, E. (2012). Neuro-ophthalmology of movement disorders. Current Opinion in Ophthalmology. https://doi.org/10.1097/icu.0b013e328358ba14
119. Cleator, J., Abbott, J., Judd, P. A., Sutton, C., & Wilding, J. (2012). Night eating syndrome: implications for severe obesity. Nutrition and Diabetes. https://doi.org/10.1038/nutd.2012.16
120. Cock, H. R., & Edwards, M. J. (2018). Functional neurological disorders: acute presentations and management. Clinical Medicine. https://doi.org/10.7861/clinmedicine.18-5-414
121. Coghill, D., Bonnar, S., Duke, S. E., Graham, J., & Seth, S. G. (2009). Pre-school problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0006
122. Cohen, J. A., Mowchun, J. J., Lawson, V. H., & Robbins, N. M. (2016). A 44-Year-Old Man with Bilateral Facial Droop. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190491901.003.0017
123. Cojocaru, I. M., Cojocaru, M., Siloşi, I., & Vrabie, C. D. (2010). Central Nervous System Manifestations in Rheumatic Diseases. Journal of Medical Biochemistry. https://doi.org/10.2478/v10011-010-0014-y
124. Colomé, R., Sans, A., López‐Sala, A., & Boix, C. (2009). [Non-verbal learning disorder: cognitive-behavioural characteristics and neuropsychological aspects].. PubMed.
125. Constenla, I. R., Cabo, I., Lamas, P. B., & Pérez, E. M. C. (2010). Trastornos cognitivos y neuropsiquiátricos en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009737
126. Coppola, G., Pastorino, G. M. G., Morcaldi, L., D’Onofrio, F., & Operto, F. F. (2020). Psychogenic Non-Epileptic Status as Refractory, Generalized Hypertonic Posturing: Report of Two Adolescents. Medicina. https://doi.org/10.3390/medicina56100508
127. Cortés, M. D. C. M. (2013). Análisis evolutivo y valoración neuropsicológica integral de pacientes con deterioro cognitivo leve o enfermedad de Alzheimer..
128. Costanza, A., Amerio, A., Aguglia, A., Escelsior, A., Serafini, G., Berardelli, I., Pompili, M., & Amore, M. (2020). When Sick Brain and Hopelessness Meet: Some Aspects of Suicidality in the Neurological Patient. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527319666200611130804
129. Costello, I., Phadke, R. V., & Shah, N. (2011). Sporadic Creutzfeldt-Jakob disease: a rare cause of rapid cognitive decline in a patient with systemic lupus erythematosus. The Journal of the Royal College of Physicians of Edinburgh. https://doi.org/10.4997/jrcpe.2011.106
130. Courchesne, E., Redcay, E., Morgan, J. T., & Kennedy, D. P. (2005). Autism at the beginning: Microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism. Development and Psychopathology. https://doi.org/10.1017/s0954579405050285
131. Couser, N. L., Masood, M. M., Aylsworth, A. S., & Stevenson, R. E. (2017). Ocular manifestations in the X-linked intellectual disability syndromes. Ophthalmic Genetics. https://doi.org/10.1080/13816810.2016.1247459
132. Creten, C., Zwaan, S. V. D., Blankespoor, R. J., Maatkamp, A., Klinkenberg, S., Kranen‐Mastenbroek, V. H. V., Nicolai, J., Dhossche, D. M., Os, J. V., & Schieveld, J. N. M. (2012). [Anti-NMDA-receptor encephalitis: a new axis-III disorder in the differential diagnosis of childhood disintegrative disorder, early onset schizophrenia and late onset autism].. PubMed.
133. Crisan, H., Courtis, N. D., & Courtis, A. D. (2016). Persistent Postural-Perceptual Dizziness (PPPD): A systematic review of 10 yearsâ progress in diagnosis and treatment. Journal of Otology & Rhinology. https://doi.org/10.4172/2324-8785.1000290
134. Crucian, G. P., Armaghani, S. J., Armaghani, A., Foster, P. S., Burks, D. W., Skoblar, B., Drago, V., & Heilman, K. M. (2009). Visual–spatial disembedding in Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803390902902441
135. Cummings, J. L. (1986). Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.149.6.682
136. Cummings, J. L., & Zhong, K. (2017). Promise and Challenges in Drug Development and Assessment for Cognitive Enhancers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214401.003.0001
137. Dalbro, S. E. J., & Kerty, E. (2024). Synsvansker ved Parkinsons sykdom. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.23.0716
138. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
139. Dan, B. (2023). Neurodevelopmental impairment advantage: The ability capital. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.15723
140. Datta, A., & Bürki, S. (2024). Sleep-related epilepsies in the course of development in childhood. Deleted Journal. https://doi.org/10.1007/s10309-024-00720-6
141. Daum, I., & Ackermann, H. (1997). Nondeklaratives Gedächtnis - neuropsychologische Befunde und neuroanatomische Grundlagen. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2007-996316
142. Delattre, J., Moll, J., Antoine, J. C., Brashear, H. R., Drlicek, M., Dropcho, E. J., Giometto, B., Graus, F., Greenlee, J., Honnorat, J., Jaeckle, K. A., Tanaka, K., & Vecht, C. (1995). Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies. Neurology. https://doi.org/10.1212/wnl.45.10.1937
143. Delgado, D. A. O., Rojas, M. C. O., & Olea, J. M. S. (2024). Episodio depresivo mayor de características catatónicas: Reporte de caso. Revista Científica de Salud y Desarrollo Humano. https://doi.org/10.61368/r.s.d.h.v5i1.75
144. Demiryürek, B. E., Acar, B. A., Ceylan, M., Demiryürek, E., & Yaylacı, S. (2017). Impact of surgery on Lewy body dementia: two cases presentation. Ortadoğu Tıp Dergisi. https://doi.org/10.21601/ortadogutipdergisi.293150
145. Derouesné, C. (2006). Dementia with Lewy bodies: third report of DLB consortium. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
146. Derouesné, C. (2006). Démence à corps de Lewy : nouveau consensus. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
147. Desseilles, M., Sterpenich, V., Dang‐Vu, T. T., & Schwartz, S. (2011). REM sleep and emotion regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511921179.044
148. Deuschl, G., & Elble, R. J. (2009). Essential tremor — Neurodegenerative or nondegenerative disease towards a working definition of ET. Movement Disorders. https://doi.org/10.1002/mds.22755
149. Devinsky, O., & D’Esposito, M. (2003). Attention and Attentional Disorders. https://doi.org/10.1093/oso/9780195137644.003.0004
150. Devlin, A. (2003). Paediatric neurological examination. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.9.2.125
151. Devlin, A. (2003). Paediatric neurological examination. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.99.47
152. Diamond, G., Senecky, Y., Keren, M., Inbar, D., Shufer, A., & Cohen, H. (2006). PSEUDONEUROLOGICAL SYNDROME IN INSTITUTIONALIZED INFANTS PRIOR TO BONDING AND ADOPTION. Neuropediatrics. https://doi.org/10.1055/s-2006-945637
153. Dickerson, B. C., & Sperling, R. A. (2007). Dementia: mild cognitive impairment and Alzheimer’s disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566298.003.0005
154. Dickson, D. W., & Orr, C. (2011). Neuropathology of Dementia in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch14
155. Dighe, N. S., Laware, R. B., Bhawar, S. B., Musmade, D. S., Gaware, V. M., Hole, M. B., & Arote, S. R. (2010). CREUTZFELDT-JAKOB DISEASE: AN OVERVIEW.
156. Ding, K., Gupta, P. K., & Diaz‐Arrastia, R. (2016). Epilepsy after Traumatic Brain Injury. CRC Press, Taylor and Francis Group eBooks.
157. Dobre, M., Popa, P., Aurel, N., & Georgescu, L. P. (2009). Clinical and paraclinical aspects in mental retarda tion and autism spectrum disorders Retardul mentali tulbur ările din spectrul autist - aspecte clinicei paraclinice.
158. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
159. Doghramji, P. P., Lieberman, J. A., & Gordon, M. L. (2007). Stay awake! Understanding, diagnosing, and successfully managing narcolepsy.. PubMed.
160. Domoto‐Reilly, K., Sapolsky, D., & Dickerson, B. C. (2014). Mild Cognitive Impairment (MCI) Stage of the Frontotemporal Dementias: Early Diagnosis and Management. Perspectives on Gerontology. https://doi.org/10.1044/gero19.2.57
161. Donaghy, M., & Rossor, M. N. (2011). Psychologically determined disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198569381.003.0153
162. Donaghy, P. C., & McKeith, I. G. (2014). The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimer s Research & Therapy. https://doi.org/10.1186/alzrt274
163. Doty, R. L., & Tekelı, H. (2012). Chapter 9. Olfactory function in Parkinson’s disease. Advances in consciousness research. https://doi.org/10.1075/aicr.85.16dot
164. Dubrovsky, A., Corderí, J., Karasarides, T., & Taratuto, A. L. (2012). Pompe disease, the must‐not‐miss diagnosis: A report of 3 patients. Muscle & Nerve. https://doi.org/10.1002/mus.23643
165. Ducharme, S., Price, B. H., & Dickerson, B. C. (2017). Apathy: a neurocircuitry model based on frontotemporal dementia. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2017-316277
166. Duncan, J. S., Sander, J. W., Alim‐Marvasti, A., Balestrini, S., Baxendale, S., Bindman, D., Chinthapalli, K., Chowdhury, F. A., Diehl, B., Eriksson, S., Foong, J., Heaney, D., Khan, S., Koepp, M. J., Kullmann, D. M., Rajakulendran, S., Rugg‐Gunn, F., Sidhu, M. K., Sisodiya, S. M., ... Yogarajah, M. (2024). Epilepsy and Related Disorders. Neurology. https://doi.org/10.1002/9781119715672.ch10
167. Duntley, S. P. (2004). Insomnia in Primary Sleep Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_12
168. Durán‐McKinster, C., Rodrı́guez-Jurado, R., Ridaura, C., Orozco-Covarrubias, M. A. D. L. L., Tamayo, L., & Ruiz-Maldonando, R. (1999). Elejalde Syndrome—A Melanolysosomal Neurocutaneous Syndrome. Archives of Dermatology. https://doi.org/10.1001/archderm.135.2.182
169. Dziegielewski, S. F. (2014). Quick References. https://doi.org/10.1002/9781394260577.bapp01
170. D’Amico, A., & Bertini, E. (2019). Neonatal Hypotonia. Neurology. https://doi.org/10.1016/b978-0-323-54392-7.00013-3
171. Ebadi, M., Tippin, J., Chou, K. L., Erickson, B. A., Doerschug, K. C., & Fletcher, D. M. J. (2011). Non-motor Symptoms in Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2011.07.02.113
172. Ebadi, M., Tippin, J., Chou, K. L., Erickson, B. A., Doerschug, K. C., & Fletcher, D. M. J. (2012). Non-motor Symptoms in Parkinson’s Disease. European Neurological Review. https://doi.org/10.17925/enr.2012.07.01.35
173. Efrosini, Z., & Dimitrios, T. (2012). Non-Conventional MRI Techniques in Neurophychiatric Systemic Lupus Erythematosus (NPSLE): Emerging Tools to Elucidate the Pathophysiology and Aid the Diagnosis and Management. InTech eBooks. https://doi.org/10.5772/24627
174. Elefante, C., Lattanzi, L., Ismail, Z., Medda, P., Bacciardi, S., Mainardi, C., & Perugi, G. (2019). Mild Behavioral Impairment: presentation of the diagnostic criteria and the Italian version of the MBI-Checklist.. PubMed. https://doi.org/10.1708/3142.31246
175. Elkan, E.-M., Papuc, A.-M., Goroftei, R. E. B., Banu, E. A., Zlati, M. L., Albeanu, A. G., & Pleșea-Condratovici, A. (2023). DREAMING AND PARASOMNIAS FROM A CEREBRAL STRUCTURAL VIEW. https://doi.org/10.35630/2022/12/psy.ro.6
176. Elvevåg, B., & Goldberg, T. E. (2000). Cognitive Impairment in Schizophrenia Is the Core of the Disorder. Critical Reviews in Neurobiology. https://doi.org/10.1615/critrevneurobiol.v14.i1.10
177. Emre, M. (2003). What causes mental dysfunction in Parkinson's disease?. Movement Disorders. https://doi.org/10.1002/mds.10565
178. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
179. Ercika, L., & Taube, M. (2025). Case Report: Lewy body dementia with unusual psychotic symptoms, atypically late parkinsonism, and patient sensitivity to first generation antipsychotics. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1551581
180. Esparcia, P. G. (2016). Identification of a risk transcriptome and proteome in Parkinson’s disease, Dementia with Lewy bodies and rapidly progressive Dementia with Lewy bodies.
181. Espay, A. J., Aybek, S., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., LaFaver, K., LaFrance, W. C., Lang, A. E., Nicholson, T. R., Nielsen, G., Reuber, M., Voon, V., Stone, J., & Morgante, F. (2018). Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2018.1264
182. Evren, A., Güven, T., Aslantas-Ertekin, B., & Yaluğ, İ. (2011). The Neuropsychiatric Consequences of Childhood Encephalitis: A Review of Cases from Middle-Eastern Countries. InTech eBooks. https://doi.org/10.5772/20459
183. Factor, S. A., Molho, E., Podskalny, G. D., & Brown, D. (1995). Parkinson's disease: drug-induced psychiatric states.. PubMed.
184. Falk, M. J., & Moreno, M. A. (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
185. Fantini, M. L., Ferini‐Strambi, L., & Montplaisir, J. (2005). Idiopathic REM sleep behavior disorder. Neurology. https://doi.org/10.1212/01.wnl.0000152878.79429.00
186. Farah, M. J., & Feinberg, T. E. (2005). Patient-Based Approaches to Cognitive Neuroscience. https://doi.org/10.7551/mitpress/5268.001.0001
187. Fatani, M. I., Wani, A. M., Manjaly, M., Hussain, W. M., Turkistani, A., Showkat, K., Maimani, G. A., Qadmani, A., & Akhtar, M. (2009). Delirium in a 74-year-old man: correct imaging revealed the truth. BMJ Case Reports. https://doi.org/10.1136/bcr.07.2009.2070
188. Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015). REM Sleep Behavior Disorder (RBD) as a marker od neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/000298292014238
189. Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015). REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039822014238
190. Ferini‐Strambi, L., Sforza, M., Poletti, M., Giarrusso, F., & Galbiati, A. (2017). Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA). La Medicina del lavoro. https://doi.org/10.23749/mdl.v108i4.6497
191. Ferman, T. J., & Boeve, B. F. (2012). Sleep in Parkinson’s Disease and Dementia with Lewy Bodies. Advances in biological psychiatry. https://doi.org/10.1159/000331527
192. Ferman, T. J., Boeve, B. F., Smith, G. E., Silber, M. H., Lucas, J. A., Graff‐Radford, N. R., Dickson, D. W., Parisi, J. E., Petersen, R. C., & Ivnik, R. J. (2002). Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617702870047
193. Fernández, I. S., Loddenkemper, T., Peters, J. M., & Kothare, S. V. (2012). Electrical Status Epilepticus in Sleep: Clinical Presentation and Pathophysiology. Pediatric Neurology. https://doi.org/10.1016/j.pediatrneurol.2012.06.016
194. Ferreira, J. M. S., Oliveira, V. N., Fraga, L. R., & Sardinha, G. D. (2024). DEMÊNCIA POR CORPÚSCULOS DE LEWY: UM PANORAMA ATUAL. Revista Ibero-Americana de Humanidades, Ciências e Educação. https://doi.org/10.51891/rease.v10i10.15919
195. Figueredo-Rodríguez, P., Río‐Portilla, Y. D., Sánchez-Romero, J. I., Pérez-Ortiz, A., & Corsi‐Cabrera, M. (2009). La actividad Alfa frontal en insomnes primarios con dificultad para iniciar el sueño. Salud Mental.
196. Firth, P. G., & Bolay, H. (2004). Transient High Altitude Neurological Dysfunction: An Origin in the Temporoparietal Cortex. High Altitude Medicine & Biology. https://doi.org/10.1089/152702904322963708
197. Fitó, A. S., Roura, R. C., López‐Sala, A., Lluch, C. B., López, J. M., Rebollo, M., Julià, M. G., Póo, L. C., & Plana, J. C. (2011). Amnesia del desarrollo como secuela cognitiva focal de patología neonatal. Revista de Neurología. https://doi.org/10.33588/rn.52s01.2010803
198. Flanagan, M. E., Sonnen, J. A., Keene, C. D., Hevner, R. F., & Montine, T. J. (2017). Molecular Basis of Diseases of the Nervous System. Molecular Pathology. https://doi.org/10.1016/b978-0-12-802761-5.00029-8
199. Fluss, J., Billard, C., & Pinton, F. (2009). Specific language impairment versus Landau‐Kleffner syndrome. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02213.x
200. Foley, C. M. (2017). Delirium. Routledge eBooks. https://doi.org/10.4324/9781315382760-62
201. Fontenelle, L. F., Mendlowicz, M. V., Gillin, J. C., Mattos, P., & Versiani, M. (2000). Neuropsychological sequelae in Kleine-Levin syndrome: case report. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2000000300021
202. Fowler, N. R., Gao, S., Frame, A., Perkins, A. J., Monahan, P. O., & Boustani, M. (2011). P2‐432: Who refuses diagnostic assessment for dementia?. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2011.05.1305
203. Fragoso, Y. D., Rocha, F. B., Beloni, T. M. N., Orquiza, B., Rosa, P. B., Donadel, R. W., Aniceto, J. T., & Diniz, R. P. (2016). Driving Ability among Patients with Multiple Sclerosis: Can Legislation Be Provided on the Matter?. Critical Reviews in Physical and Rehabilitation Medicine. https://doi.org/10.1615/critrevphysrehabilmed.2017020023
204. Frattali, C., & Duffy, J. R. (2005). Characterizing and Assessing Speech and Language Disturbances. Humana Press eBooks. https://doi.org/10.1385/1-59259-834-x:255
205. Freidenberg, D. L., Huber, S. J., Shuttleworth, E. C., Paulson, G. W., & Christy, J. A. (1989). Neuropsychological impairments associated with severity of Parkinson's disease. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.1.2.154
206. Friedman, J. H., & Fernandez, H. H. (2000). THE NONMOTOR PROBLEMS OF PARKINSONʼS DISEASE. The Neurologist. https://doi.org/10.1097/00127893-200006010-00004
207. Fénelon, G. (2006). [Psychotic symptoms in Parkinson's disease].. PubMed.
208. Ga, C.-O. (2006). Paroxysmal neurogenetic and neurometabolic disorders.
209. Gagnon, J., Bertrand, J., & Marchand, D. G. (2012). Cognition in Rapid Eye Movement Sleep Behavior Disorder. Frontiers in Neurology. https://doi.org/10.3389/fneur.2012.00082
210. Gaig, C., Valldeoriola, F., Gelpí, E., Ezquerra, M., Llufriú, S., Buongiorno, M., Rey, M., Martı́, M. J., Graus, F., & Tolosa, E. (2011). Rapidly progressive diffuse Lewy body disease. Movement Disorders. https://doi.org/10.1002/mds.23506
211. Galanopoulou, A. S., Vidaurre, J., McVicar, K., Ballaban‐Gil, K., Shinnar, S., Tuchman, R., & Moshé, S. L. (2002). Language and Behavioral Disturbances Associated with Epileptiform EEGs. American Journal of Electroneurodiagnostic Technology. https://doi.org/10.1080/1086508x.2002.11079399
212. Galasko, D. (1999). A CLINICAL APPROACH TO DEMENTIA WITH LEWY BODIES. The Neurologist. https://doi.org/10.1097/00127893-199909000-00002
213. Galbiati, A., Carli, G., Hensley, M., & Ferini‐Strambi, L. (2018). REM Sleep Behavior Disorder and Alzheimer’s Disease: Definitely No Relationship?. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-171164
214. Galpern, W. R., & Lang, A. E. (2006). Interface between tauopathies and synucleinopathies: A tale of two proteins. Annals of Neurology. https://doi.org/10.1002/ana.20819
215. Gandolfi, M., Sandri, A., Mariotto, S., Tamburin, S., Paolicelli, A. M., Fiorio, M., Pedrotti, G., Barone, P., Pellecchia, M. T., Erro, R., Cuoco, S., Carotenuto, I., Vinciguerra, C., Botto, A., Zenere, L., Canu, E., Sibilla, E., Filippi, M., Sarasso, E., ... Tinazzi, M. (2024). A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders. PLoS ONE. https://doi.org/10.1371/journal.pone.0309408
216. Gangopadhaya, P., Mitra, K., & Das, S. (2003). Parkinsonism plus syndrome--a review.. PubMed.
217. Ganguly, D., Ghosh, S., Banerjee, M., Alam, A., Ghosh, R., & Ghosh, M. S. (2023). None. International Journal of Pharmaceutical Sciences and Research. https://doi.org/10.13040/ijpsr.0975-8232.14(2).661-73
218. Ganguly, J., Banerjee, S., Basu, P., Mukherjee, S., Singh, N., & Kumar, H. (2025). Teaching Video NeuroImage: String Hallucinations in Parkinson Disease. Neurology. https://doi.org/10.1212/wnl.0000000000213611
219. Garcia, C. P., Sacks, S. A., & Mamani, A. G. W. D. (2012). Neurocognition and Cognitive Biases in Schizophrenia. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0b013e3182614264
220. Garcia, G., Andrés, L. R., Campos, A. R., Borge, L. G., & Toranzo, E. M. (2016). Recurrent hypersomnia: Kleine-Levin syndrome. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.2220
221. García, G. G., & Coderch, J. (2011). ¿El deterioro cognitivo en los primeros episodios de esquizofrenia es generalizado o selectivo?. Alzheimer Realidades e investigación en demencia. https://doi.org/10.5538/1137-1242.2011.48.18
222. García-Ogueta, M. I. (2001). Mecanismos atencionales y síndromes neuropsicológicos. Revista de Neurología.
223. Garg, R. K., Karak, B., & Misra, S. (1999). Neurological manifestations of malaria : an update.. PubMed.
224. Gaspar, B. L. (2023). Classification of Immune-Mediated Neuropathies. https://doi.org/10.1007/978-981-19-8421-1_16
225. Gaspar, B. L. (2023). Diagnostic Evaluation of Immune-Mediated Neuropathies. https://doi.org/10.1007/978-981-19-8421-1_15
226. Gasquoine, P. G. (2011). Cognitive impairment in common, noncentral nervous system medical conditions of adults and the elderly. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2010.536759
227. Gayatri, N. A., Hughes, M. I., Clarke, M. A., & Martland, T. (2002). Epilepsy with reversible bulbar dysfunction. Developmental Medicine & Child Neurology. https://doi.org/10.1017/s0012162201002900
228. Geny, C. (2009). Démence parkinsonienne et démence à corps de Lewy. Neurologie com. https://doi.org/10.1684/nro.2009.0075
229. Gerards, M. (2014). Leigh syndrome: the genetic heterogeneity story continues. Brain. https://doi.org/10.1093/brain/awu264
230. Gershanik, O. S. (2002). [Dementia and cognitive impairment in Parkinson disease].. PubMed.
231. Geser, F., Wenning, G. K., Poewe, W., & McKeith, I. G. (2005). How to diagnose dementia with Lewy bodies: State of the art. Movement Disorders. https://doi.org/10.1002/mds.20535
232. Ghasia, F. F., Brunstrom, J. E., Gordon, M. O., & Tychsen, L. (2008). Frequency and Severity of Visual Sensory and Motor Deficits in Children with Cerebral Palsy: Gross Motor Function Classification Scale. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.07-0525
233. Giazkoulidou, A., Messinis, L., & Nasios, G. (2019). Cognitive functions and social cognition in multiple sclerosis: An overview.. PubMed.
234. Gireadă, B., Chiriță, V., Chiriță, R., & Dobrin, R. (2023). Young-onset dementia. New insights and a case report. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2023.2.12
235. Giubilei, F., & Orzi, F. (2014). Hetrogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039829201344
236. Giubilei, F., Candela, S. F., & Orzi, F. (2013). Heterogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism.. PubMed.
237. Gobeil, M., Guillemette, A., Silhadi, M., Charbonneau, L., Bergeron, D., Dominguez‐Vargas, A., Dancause, N., Jodoin, N., Assi, E. B., Amzica, F., Obaïd, S., & Fournier‐Gosselin, M. (2025). Local Field Potential Biomarkers of Non‐Motor Symptoms in Parkinson's Disease: Insights From the Subthalamic Nucleus in Deep Brain Stimulation. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70046
238. Goedert, M., Jakes, R., Crowther, R. A., & Spillantini, M. G. (2003). Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy as α-Synucleinopathies. Parkinson s Disease. https://doi.org/10.1385/1-59259-142-6:33
239. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
240. Gold, G. E. (2009). Dementia with Lewy Bodies: Clinical Diagnosis and Therapeutic Approach. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. https://doi.org/10.1159/000197889
241. Goldstein, D. S. (2002). Dysautonomias: Clinical Disorders of the Autonomic Nervous System. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-137-9-200211050-00011
242. Gomes, M. D. M. (2020). Unveiling sleep mysteries: neurobiology of dreaming. Revista Brasileira de Neurologia.
243. Gonzales, P. N. G., Villaraza, S. G., & Catindig, J.-A. (2024). The association between sleep and Alzheimer's disease: a systematic review. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-5764-dn-2023-0049
244. González, C. A. H., Piedrahita, C., Alzate, D., Borrero, J. J. G., Escobar, C. S. M., Otalvaro, S. O., Arango, P., Lenis, P. A. G., Varela, D. D., Molano, E. L., Ramírez, D. V. A., Rinco, A., Sánchez, J., & Hernández, V. (2020). Neuropsychiatric Aspects in a Patient Diagnosed with Corticobasal Degeneration: Clinical Case of Low Incidence and Prevalence in Colombia. Case Reports in Neurology. https://doi.org/10.1159/000509073
245. Gonçalves, M. R. R., Capelli, L., Nitríni, R., Barbosa, E. R., Porto, C. S., Lucato, L. T., & Vianna‐Morgante, A. M. (2007). ATYPICAL CLINICAL COURSE OF FXTAS: RAPIDLY PROGRESSIVE DEMENTIA AS THE MAJOR SYMPTOM. Neurology. https://doi.org/10.1212/01.wnl.0000262058.68100.ea
246. Good, W. V., Latal, B., & Ferriero, D. M. (2020). Prenatal Cocaine Exposure and the Eye. CRC Press eBooks. https://doi.org/10.1201/9781003069324-8
247. Goodwin, G. M. (1997). Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology. https://doi.org/10.1177/026988119701100204
248. Gouw, A., & Stam, C. J. (2016). Electroencephalography in the differential diagnosis of dementia.
249. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
250. Grasso, M., Piscopo, P., Confaloni, A., & Denti, M. A. (2011). 17 Neurodegenerative Disorders. Georg Thieme Verlag eBooks. https://doi.org/10.1055/b-0034-75424
251. Green, A. J. E., Andrews, M. M., Bishop, M., McKenzie, J. M., McCord, Y., Pennington, C., Chohan, G., & Knight, R. (2010). Elevated phosphorylated tau pT-181 in a possible PRNP codon 129 MV vCJD case. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2009.183418
252. Greenfield, M. J., Fobian, A. D., Fargason, R. E., & Birur, B. (2024). Optimizing outcomes when treating functional neurological disorder in acute care settings: case reports depicting the value of diagnostic precision and timely and appropriate psychological interventions using an interdisciplinary framework. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2024.1288828
253. Gregory, A., Kurian, M. A., Haack, T. B., Hayflick, S. J., & Hogarth, P. (2017). Beta-Propeller Protein-Associated Neurodegeneration.
254. Gresty, M. A., & Ohlmann, T. (2003). Motorists Vestibular Disorientation Syndrome Revisited.
255. Grieco, J. A., Pulsifer, M. B., Seligsohn, K., Skotko, B. G., & Schwartz, A. (2015). Down syndrome: Cognitive and behavioral functioning across the lifespan. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.31439
256. Griffiths-King, D., Hodgekins, J., Chouinard, P. A., Chouinard, V.-A., & Sperandio, I. (2016). A review of abnormalities in the perception of visual illusions in schizophrenia. Psychonomic Bulletin & Review. https://doi.org/10.3758/s13423-016-1168-5
257. Groisman, A. E., & Seminatore, M. L. (2003). Children and Adolescents Who Have Schizophrenia. Pediatrics in Review. https://doi.org/10.1542/pir.24.10.356
258. Grool, A. M. (2012). White matters - The influence of cerebral small-vessel disease on depression, cognition and functioning.
259. Guamanarca, R. I. S., Loraque, N. B., Rubio, A. L., García, M. M., Lupiañez, I. J., & Llaría, M. M. M. (2025). SÍNDROME DE EKBOM EN PACIENTE GERIÁTRICO. A PROPÓSITO DE UN CASO.. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2025.31.47.002
260. Guarnieri, B., Adorni, F., Musicco, M., Appollonio, I., Bonanni, E., Caffarra, P., Caltagirone, C., Cerroni, G., Concari, L., Cosentino, F., Ferrara, S., Fermi, S., Ferri, R., Gelosa, G., Lombardi, G., Mazzei, D., Mearelli, S., Morrone, E., Murri, L., ... Sorbi, S. (2012). Prevalence of Sleep Disturbances in Mild Cognitive Impairment and Dementing Disorders: A Multicenter Italian Clinical Cross-Sectional Study on 431 Patients. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000335363
261. Guerrini, R., & Falchi, M. (2011). Dravet syndrome and <i>SCN1A</i> gene mutation related‐epilepsies: cognitive impairment and its determinants. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.03966.x
262. Guerrini, R., & Genton, P. (2004). Epileptic Syndromes and Visually Induced Seizures. Epilepsia. https://doi.org/10.1111/j.0013-9580.2004.451011.x
263. Guerrini, R., & Pellacani, S. (2012). Benign childhood focal epilepsies. Epilepsia. https://doi.org/10.1111/j.1528-1167.2012.03609.x
264. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
265. Guzman‐Limon, M., Amatya, S., Samuels, J., Swinford, R. D., Bhatnagar, S., & Samuel, J. P. (2017). Cefepime‐induced neurotoxicity in a pediatric patient on chronic hemodialysis: a case report. Clinical Case Reports. https://doi.org/10.1002/ccr3.1217
266. Gélinas, C., Klein, K., Naidech, A., & Skrobik, Y. (2013). Pain, Sedation, and Delirium Management in the Neurocritically Ill: Lessons Learned from Recent Research. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/s-0033-1342986
267. Hadden, R. D. M., Lunn, M. P., & Hughes, R. A. C. (1999). Autoimmune Inflammatory Neuropathy. Journal of the Royal College of Physicians of London. https://doi.org/10.1016/s0035-8819(25)01713-1
268. Hadders‐Algra, M. (2003). Developmental Coordination Disorder: Is Clumsy Motor Behavior Caused by a Lesion of the Brain at Early Age?. Neural Plasticity. https://doi.org/10.1155/np.2003.39
269. Hadi, I., Wijayati, F., Usman, R. D., & Rosyanti, L. (2017). Major Depressive Disorder: A Mini Review. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v9i1.102
270. Hainline, B., Gurin, L., & Torres, D. M. (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
271. Hamdan, F. F., Holder, J. L., & Michaud, J. L. (2019). SYNGAP1-Related Intellectual Disability.
272. Hamed, S. A. (2014). Diabetes mellitus and the brain : special emphasis on cognitive function : review. The South African journal of diabetes & vascular disease.
273. Han, I.-W., & Seo, S. (1997). Memory Impairment in Dementing Patients. Sleep Medicine and Psychophysiology.
274. Hanağası, H., Bılgıç, B., & Emre, M. (2016). Dementia with Lewy bodies and Parkinson’s disease dementia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199655946.003.0036
275. Harvey, P. D. (2011). Assessment of everyday functioning in schizophrenia.. PubMed.
276. Hauw, J., Hausser‐Hauw, C., Girolami, U. D., Hasboun, D., & Seilhean, D. (2011). Neuropathology of Sleep Disorders: A Review. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1097/nen.0b013e318211488e
277. Hawes, D. J., & Scalise, P. (2005). Childhood depression: early risk and resilience and introducing solids to infants. https://doi.org/10.4225/50/5552facc15227
278. Hayes, D. (2006). Narcolepsy with Cataplexy in Early Childhood. Clinical Pediatrics. https://doi.org/10.1177/000992280604500409
279. Hehr, U., Uyanık, G., Aigner, L., Couillard‐Després, S., & Winkler, J. (2011). DCX-Related Disorders.
280. Heilbroner, P. L., & Castaneda, G. Y. (2007). Pediatric neurology : essentials for general practice. Lippincott Williams & Wilkins eBooks.
281. Heimer, G., Gregory, A., Hogarth, P., Hayflick, S. J., & Zeev, B. B. (2019). MECR-Related Neurologic Disorder.
282. Hindle, J. V. (2010). Ageing, neurodegeneration and Parkinson's disease. Age and Ageing. https://doi.org/10.1093/ageing/afp223
283. Hoffman, S., Hobson, J. A., Helfand, R., & Kostner, D. (1987). Dream bizarreness and the activation-synthesis hypothesis.. PubMed.
284. Holditch‐Davis, D. (2014). Development of Sleep and Sleep Problems in Preterm Infants.
285. Hoppes, C. W., Morrell, R. L., Woelfel, L. W., & Whitney, S. L. (2019). Dizziness in a Child With Irlen Syndrome: Differentiating Visual and Vestibular Complaints. Pediatric Physical Therapy. https://doi.org/10.1097/pep.0000000000000652
286. Hosseinbor, N., & Bakhshani, N.-M. (2014). Djinnati Syndrome in Baluchistan: The Role of Traumatic and Abuse Experiences on Individual Vulnerability. international journal high risk behaviors & addiction. https://doi.org/10.5812/ijhrba.23610
287. Hou, S., & Rabchevsky, A. G. (2014). Autonomic Consequences of Spinal Cord Injury. Comprehensive physiology. https://doi.org/10.1002/cphy.c130045
288. Hou, S., & Rabchevsky, A. G. (2014). Autonomic Consequences of Spinal Cord Injury. Comprehensive physiology. https://doi.org/10.1002/j.2040-4603.2014.tb00584.x
289. Howard, R., Kullmann, D. M., Paget, A., Spillane, J., & Waraich, M. (2024). Disorders of Consciousness and Intensive Care Neurology. Neurology. https://doi.org/10.1002/9781119715672.ch28
290. Howell, M. J. (2020). Rapid Eye Movement Sleep Behavior Disorder and Other Rapid Eye Movement Parasomnias. CONTINUUM Lifelong Learning in Neurology. https://doi.org/10.1212/con.0000000000000896
291. Huang, C., Chu, C., Lin, Y., Lin, Y., Huang, H., & Chang, Y.-C. (2022). Retinopathy of Prematurity Is a Biomarker for Pathological Processes in the Immature Brain. Neonatology. https://doi.org/10.1159/000526652
292. Husain, S., & Gn, M. (2007). Early nerve damage in leprosy: An electrophysiological study of ulnar and median nerves in patients with and without clinical neural deficits. Neurology India. https://doi.org/10.4103/0028-3886.30422
293. Huys, A. M. L. (2020). Functional Movement Disorders: Attention, Agency and Beliefs. Doctoral thesis, UCL (University College London)..
294. Hyndych, A., El‐Abassi, R., & Mader, E. C. (2025). The Role of Sleep and the Effects of Sleep Loss on Cognitive, Affective, and Behavioral Processes. Cureus. https://doi.org/10.7759/cureus.84232
295. Hämäläinen, P., & Rosti‐Otajärvi, E. (2016). Cognitive impairment in MS: rehabilitation approaches. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.12650
296. Ibrahim, I. R., & Amar, K. (2007). Mild cognitive impairment. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2007.68.10.27322
297. Ibáñez, A. G., Bolumburu, E. U., & Torres, C. V. (2012). Estado epiléptico no convulsivo en el siglo XXI: clínica, diagnóstico, tratamiento y pronóstico. Revista de Neurología. https://doi.org/10.33588/rn.5402.2011250
298. Ibáñez, Á. S., Vásquez, V. C., & Laborda, M. A. (2017). Alucinaciones visuales y funcionamiento cognitivo en pacientes con déficit visual adquirido.. Cuadernos de neuropsicología.
299. Iijima, M. (2018). Odor dysfunction in Parkinson’s disease and neurodegenerative diseases. Journal of Japan Association on Odor Environment. https://doi.org/10.2171/jao.49.370
300. Ince, P. G. (2011). Dementia with Lewy Bodies and Parkinson's Disease Dementia. https://doi.org/10.1002/9781444341256.ch22
301. Ishikawa, A. (1997). [Diffuse Lewy body disease].. PubMed.
302. İrkeç, C., Vurallı, D., & Ozkalaycı, S. K. (2013). Restless Legs Syndrome as the Initial Presentation of Multiple Sclerosis. Case Reports in Medicine. https://doi.org/10.1155/2013/290719
303. Jabbari, B., & Vaziri, N. D. (2017). The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodialysis International. https://doi.org/10.1111/hdi.12587
304. Jahns, H., Vernau, K. M., Nolan, C. M., O’Neill, E. J., Shiel, R. E., & Shelton, G. D. (2020). Polyneuropathy in Young Siberian Huskies Caused by Degenerative and Inflammatory Diseases. Veterinary Pathology. https://doi.org/10.1177/0300985820934112
305. Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2007.131045
306. Javitt, D. C. (2009). When Doors of Perception Close: Bottom-up Models of Disrupted Cognition in Schizophrenia. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev.clinpsy.032408.153502
307. Jellinger, K. A. (2000). Morphological substrates of mental dysfunction in Lewy body disease: an update. https://doi.org/10.1007/978-3-7091-6781-6_21
308. Jellinger, K. A. (2024). Mild cognitive impairment in Parkinson's disease: current view. Frontiers in Cognition. https://doi.org/10.3389/fcogn.2024.1369538
309. Jenkins, T. M., Brockington, A., & Shaw, P. J. (2020). The motor neuron diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0604
310. Jennum, P., Cano, J. S., Bassetti, C. L., Clarenbach, P., Högl, B., Mathis, J., Poirrier, R., Šonka, K., Svanborg, E., Grosel, L. D., Kaynak, D., Kruger, M., Papavasiliou, A., & Zahariev, Z. (2011). Sleep Disorders in Neurodegenerative Disorders and Stroke. https://doi.org/10.1002/9781444346268.ch10
311. Jennum, P., Christensen, J. A. E., & Zoetmulder, M. (2016). Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development. Nature and Science of Sleep. https://doi.org/10.2147/nss.s99240
312. Jiménez, M. S. B., & Salgado, M. D. (2001). Demencia en pacientes con parálisis supranuclear progresiva. Revista de Neurología. https://doi.org/10.33588/rn.3211.2000159
313. Jin, J. Y., Kim, B., & Lee, S. (2014). Three Cases of Rapid Eye Movement Sleep Behavior Disorder after Encephalitis. Journal of Korean Sleep Research Society. https://doi.org/10.13078/jksrs.14007
314. Johansson, J., Lindstedt, M., Ygge, J., & Borg, K. (2019). Vision-related symptoms after acquired brain injury and the association with mental fatigue, anxiety and depression. Journal of Rehabilitation Medicine. https://doi.org/10.2340/16501977-2570
315. Johnson, M., Shafi, N., Parker, J. C., & Parker (2005). Dementia with Lewy bodies: a commonly unrecognized cause of dementia..
316. Ju, Y. S., Videnović, A., & Vaughn, B. V. (2017). Comorbid Sleep Disturbances in Neurologic Disorders. CONTINUUM Lifelong Learning in Neurology. https://doi.org/10.1212/con.0000000000000501
317. K.Pavithra, P., Rhea, A., M.Dhanraj, D., & Pravinya, P. (2018). Prosthodontic Management of a Patient with Parkinson’s disease- A Case Report. Journal of Young Pharmacists. https://doi.org/10.5530/jyp.2018.10.84
318. Kabel, A. M., & Maghrabi, I. A. (2014). Sleep and its disorders. El Mednifico Journal. https://doi.org/10.18035/emj.v2i4.255
319. Kahler, S. G., & Fahey, M. (2003). Metabolic disorders and mental retardation. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.10018
320. Kalayjian, L. A., & Morrell, M. J. (2000). Female Sexuality and Neurological Disease. Journal of Sex Education and Therapy. https://doi.org/10.1080/01614576.2000.11074333
321. Kalita, J., Misra, U. K., & Nair, P. (2008). Diagnostic approach to peripheral neuropathy. Annals of Indian Academy of Neurology. https://doi.org/10.4103/0972-2327.41875
322. Kane, I., Light, M. J., Osewa, I., Nobler, M. S., & Siddiqi, N. (2017). Acute psychosis with manic features in patient with Fahrs syndrome: A Case report and Clinical review. Neuropsychiatry. https://doi.org/10.4172/neuropsychiatry.1000207
323. Kanyengo, C. W. (2009). Zambia: The challenge of informing blind and deaf clients.
324. Kaplan, P. W., & Rossetti, A. O. (2011). EEG Patterns and Imaging Correlations in Encephalopathy. Journal of Clinical Neurophysiology. https://doi.org/10.1097/wnp.0b013e31821c33a0
325. Karimzadeh, P. (2012). ETHYLMALONIC ACIDURIA AND REPORT OF ONE CASE FROM IRAN. https://doi.org/10.22037/ijcn.v6i1.2899
326. Karimzadeh, P. (2012). Psycho-cognitive behavioral problems in sleep disordered children.. PubMed. https://doi.org/10.3969/j.issn.1673-5374.2012.08.012
327. Kaufman, D. I., Trobe, J. D., Eggenberger, E., & Whitaker, J. N. (2000). Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis [RETIRED]. Neurology. https://doi.org/10.1212/wnl.54.11.2039
328. Kaufmann, H., & Biaggioni, I. (2003). Autonomic Failure in Neurodegenerative Disorders. Seminars in Neurology. https://doi.org/10.1055/s-2004-817719
329. Keir, L. H. M., & Breen, D. P. (2020). REM sleep behaviour disorder in patients without synucleinopathy. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2020-323475
330. Kempster, P., Williams, D. R., Selikhova, M., Holton, J., Révész, T., & Lees, A. J. (2007). Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain. https://doi.org/10.1093/brain/awm142
331. Kerchner, G. A., & Rosenbloom, M. (2014). Frontotemporal Neurocognitive Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg65
332. Kesler, A., & Korczyn, A. D. (2006). Visual disturbances in Parkinson's disease. Practical Neurology. https://doi.org/10.1136/jnnp.2006.088286
333. Khan, S., Bhattal, G., Shah, N., Lascano, J., & Karki, A. (2019). Neuroborreliosis with Unusual Presentation: A Case Report. Cureus. https://doi.org/10.7759/cureus.5758
334. Khotianov, N., Singh, R., & Singh, S. (2002). Lewy body dementia: case report and discussion.. PubMed.
335. Kim, S. J., Shin, M. G., & Lee, J. (2008). A Case of Orbital Malignant Lymphoma associated with Acquired Immunodeficiency Syndrome (AIDS). Journal of the Korean Ophthalmological Society. https://doi.org/10.3341/jkos.2008.49.9.1543
336. Kirshner, H. S. (1984). Language Disturbance. Archives of Neurology. https://doi.org/10.1001/archneur.1984.04050170037012
337. Kish, S. J., & Hornykiewicz, O. (1984). Neurochemical Basis of Dementia in Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100046382
338. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
339. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. DeckerMed Family Medicine. https://doi.org/10.2310/fm.1336
340. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. https://doi.org/10.2310/neuro.1336
341. Knopman, D. S., & Jankowiak, J. (2005). Not all dementia is Alzheimer: Dementia with Lewy bodies. Neurology. https://doi.org/10.1212/01.wnl.0000194990.62816.4c
342. Knudsen, S., Gammeltoft, S., & Jennum, P. (2010). Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain. https://doi.org/10.1093/brain/awp320
343. Knupp, K. G., & Wirrell, E. (2014). Progressive myoclonic epilepsies. Neurology. https://doi.org/10.1212/wnl.0000000000000091
344. Ko, H.-Y. (2022). Neurological Deterioration After Spinal Cord Injuries. https://doi.org/10.1007/978-981-19-0228-4_41
345. Koens, L. H., Tijssen, M. A., Lange, F., Wolffenbuttel, B. H. R., Rufa, A., Zee, D. S., & Koning, T. J. D. (2018). Eye movement disorders and neurological symptoms in late‐onset inborn errors of metabolism. Movement Disorders. https://doi.org/10.1002/mds.27484
346. Kon, T., Tomiyama, M., & Wakabayashi, K. (2019). Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases. Neuropathology. https://doi.org/10.1111/neup.12597
347. Konieczka, K., & Erb, C. (2017). Diseases potentially related to Flammer syndrome. The EPMA Journal. https://doi.org/10.1007/s13167-017-0116-4
348. Konstantakopoulos, G. (2019). Insight across mental disorders: A multifaceted metacognitive phenomenon. Psychiatriki. https://doi.org/10.22365/jpsych.2019.301.13
349. Koo, B. B. (2011). Sleep-Related Movement Disorders. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805267711101010045
350. Korn‐Merker, E., Zehle, K., & Hofmann-Peters, A. (2012). Comorbidity of Epilepsy and early onset autism or Landau-Kleffner-Syndrome only?. Neuropediatrics. https://doi.org/10.1055/s-0032-1307177
351. Kos, D., Kerckhofs, E., Nagels, G., D’hooghe, M., & Ilsbroukx, S. (2007). Origin of Fatigue in Multiple Sclerosis: Review of the Literature. Neurorehabilitation and neural repair. https://doi.org/10.1177/1545968306298934
352. Kozora, E., & Filley, C. M. (2011). Cognitive Dysfunction and White Matter Abnormalities in Systemic Lupus Erythematosus. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617711000191
353. Krieger, J. E. (2000). Clinical approach to excessive daytime sleepiness.. PubMed.
354. Krishnankutty, S. V., Sanam, R., Purushothaman, P. C., & Narayani, V. (2025). ‘PRES’SING problems in pregnancy: A case report. Kerala Journal of Ophthalmology. https://doi.org/10.4103/kjo.kjo_111_23
355. Krumholz, A., Sung, G., Fisher, R. S., Barry, E. F., Bergey, G. K., & Grattan, L. M. (1995). Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. https://doi.org/10.1212/wnl.45.8.1499
356. Kukla, U., Łabuzek, K., Chronowska, J., Krzystanek, M., & Okopień, B. (2015). [Mental disorders in digestive system diseases - internist's and psychiatrist's insight].. PubMed.
357. Kuklińska, M., Sitek, E. J., Brockhuis, B., Barczak, A., Hintze, B., & Narożańska, E. (2020). Behavioural variant frontotemporal dementia – selected diagnostic dilemmas in neuropsychiatry. Aktualności Neurologiczne. https://doi.org/10.15557/an.2020.0010
358. Kulas, J. F., Dumas, J. E., & Dollison, D. M. (2003). The Diagnosis and Cognitive-Behavioral Management of Kleine-Levin Syndrome. Clinical Case Studies. https://doi.org/10.1177/1534650102239089
359. Kumar, S., Rao, S. L., Sunny, B., & Gangadhar, B. N. (2007). Widespread cognitive impairment in psychogenic anterograde amnesia. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2007.01735.x
360. Kuo, C., Tseng, H., Wu, Y., Cheng, M., Chen, P.-H., Hsieh, S., & Liu, C. (2012). Chronic Schizophrenia Comorbid with Neuropsychiatric Systemic Lupus Erythematosus. 臺灣精神醫學. https://doi.org/10.29478/tjp.201203.0007
361. Kurtis, M., Balestrino, R., Rodríguez–Blázquez, C., Forjaz, M. J., & Martínez‐Martín, P. (2018). A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders. Frontiers in Neurology. https://doi.org/10.3389/fneur.2018.00369
362. Lacassie, Y., Bobadilla, O., & Cambias, R. D. (1997). A boy with a mild case of Cornelia de Lange syndrome with above average intelligence. Journal of Intellectual & Developmental Disability. https://doi.org/10.1080/13668259700033511
363. Lamont, P. J. (2004). cognitive decline in a young adult with pre-existent developmental delay - what the adult neurologist needs to know. Practical Neurology. https://doi.org/10.1111/j.1474-7766.2004.02-206.x
364. Lanska, D. J. (2006). Functional Weakness and Sensory Loss. Seminars in Neurology. https://doi.org/10.1055/s-2006-945516
365. Lassal, R., Laurent, M., & Purper‐Ouakil, D. (2011). [Early signs of mental disorders in children aged 3-12 years].. PubMed.
366. Latronico, N., Antonini, L., Taricco, M., Vignolo, L., & Candiani, A. (2000). [Approach to the patient in vegetative state. Part II: differential diagnosis].. PubMed.
367. Lavoie, S., Polari, A., Goldstone, S., Nelson, B., & McGorry, P. D. (2019). Staging model in psychiatry: Review of the evolution of electroencephalography abnormalities in major psychiatric disorders. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12792
368. Le, C., Argilli, E., George, E., Kalaycı, T., Uyguner, Z. O., Karaman, B., Demirören, T., Héron, D., Sabatier, I., Rodan, L. H., Girisha, K. M., Radhakrishnan, P., Saunders, C., Sullivan, B., Fleming, E., Alvi, J. R., Sultan, T., Houlden, H., Efthymiou, S., ... Sherr, E. H. (2024). Basic helix-loop-helix transcription factor BHLHE22 monoallelic and biallelic variants cause a neurodevelopmental disorder with agenesis of the corpus callosum, intellectual disability, tone and movement abnormalities. medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2024.10.11.24312856
369. Lecce, E., Bellini, A., Greco, G., Martire, F., Palumbo, A. S. D., Sacchetti, M., & Bazzucchi, I. (2025). Physiological mechanisms of neuromuscular impairment in diabetes‐related complications: Can physical exercise help prevent it?. The Journal of Physiology. https://doi.org/10.1113/jp287589
370. Lee, S., Edlow, J. A., & Tarnutzer, A. A. (2025). Acute Vertigo, Dizziness and Imbalance in the Emergency Department—Beyond Stroke and Acute Unilateral Vestibulopathy—A Narrative Review. Brain Sciences. https://doi.org/10.3390/brainsci15090995
371. Lee, S., Tartaglia, C., Geschwind, M. D., Perry, D. C., Afaisen, S., Khan, B., Wu, T., Rodrı́guez, H., Ketelle, R., Steele, J. C., & Miller, B. E. (2012). Neuropsychiatric Features of Parkinsonism Dementia Complex and Other Neurodegenerative Diseases on Guam (P05.040). Neurology. https://doi.org/10.1212/wnl.78.1_meetingabstracts.p05.040
372. Lee, W. N. (2019). Novel methods of symptom measurement in Parkinson's disease.
373. Leffa, D. T., Bellaver, B., Povala, G., Ferreira, P. C., Ferrari‐Souza, J. P., Lussier, F. Z., Soares, C., Zalzale, H., Bauer‐Negrini, G., Abbas, S., Karikari, T. K., Rohde, L. A., Molina, B. S. G., & Pascoal, T. A. (2024). Attention‐deficit/hyperactivity disorder impacts the development of neuropsychiatric symptoms in Alzheimer’s disease. Alzheimer s & Dementia. https://doi.org/10.1002/alz.089857
374. Leung, M., Thompson, B., Black, J., Dai, S., & Alsweiler, J. M. (2017). The effects of preterm birth on visual development. Clinical and Experimental Optometry. https://doi.org/10.1111/cxo.12578
375. Levenson, R. W., Sturm, V. E., & Haase, C. M. (2014). Emotional and Behavioral Symptoms in Neurodegenerative Disease: A Model for Studying the Neural Bases of Psychopathology. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev-clinpsy-032813-153653
376. Levy, J. A., & Chelune, G. J. (2007). Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988707308806
377. LEÓN-CARRIÓN, M. D. R. D. M. J. (2006). Low-level responsive states. Taylor & Francis eBooks. https://doi.org/10.4324/9780203965238-15
378. Littner, M. R., Hirshkowitz, M., Kramer, M., Kapen, S., Anderson, W. M., Bailey, D. R., Berry, R. B., Davila, D., Johnson, S., Kushida, C. A., Loube, D. I., Wise, M. S., & Woodson, B. T. (2003). Practice Parameters for Using Polysomnography to Evaluate Insomnia: An Update. SLEEP. https://doi.org/10.1093/sleep/26.6.754
379. Litwin, T., Dušek, P., & Członkowska, A. (2016). Neurological manifestations in Wilson’s disease –possible treatment options for symptoms. Expert Opinion on Orphan Drugs. https://doi.org/10.1080/21678707.2016.1188003
380. Liu, H.-M., Chu, M., Li, N., Zhang, S., Zhang, Y., & Gu, P. (2018). Relationship between Sleep Quality and Cognitive Function in Patients with Mild-to-Moderate Parkinson's Disease. Chinese Medical Journal. https://doi.org/10.4103/0366-6999.229908
381. Liu, X. Z., Yuan, H., Mittal, R., & Yan, D. (2011). DFNX1 Nonsyndromic Hearing Loss and Deafness.
382. Llaría, M. M. M., Guamanarca, R. I. S., Loraque, N. B., Rubio, A. L., García, M. M., & Lupiañez, I. J. (2025). SÍNDROME DE CHARLES BONNET. A PROPÓSITO DE UN CASO.. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2025.23.73.002
383. Lock, J. H., Irani, N. K., & Newman, N. J. (2020). Neuro-ophthalmic manifestations of mitochondrial disorders and their management. Taiwan Journal of Ophthalmology. https://doi.org/10.4103/tjo.tjo_68_20
384. Loewen, A., Poulin, M. J., & Hanly, P. J. (2009). Sleep apnea in the elderly. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511770661.026
385. Lopez, S., Percio, C. D., Pascarelli, M. T., Lizio, R., Noce, G., Ferri, R., Soricelli, A., Nobili, F., Arnaldi, D., Famà, F., Bonanni, L., Franciotti, R., Onofrj, M., Fuhr, P., Gschwandtner, U., Ransmayr, G., Aarsland, D., Parnetti, L., Farotti, L., ... Babiloni, C. (2020). Different abnormalities of electroencephalographic (EEG) markers in quiet wakefulness are related to motor visual hallucinations in patients with Parkinson’s and Lewy body diseases. Alzheimer s & Dementia. https://doi.org/10.1002/alz.045811
386. Louis, E. K. S. (2019). Prognostic Counseling for Patients With Idiopathic/Isolated REM Sleep Behavior Disorder: Should We Tell Them What's Coming? Yes. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12814
387. Louis, E. K. S., Boeve, A., & Boeve, B. F. (2017). <scp>REM</scp><scp>S</scp>leep <scp>B</scp>ehavior <scp>D</scp>isorder in <scp>P</scp>arkinson's <scp>D</scp>isease and <scp>O</scp>ther <scp>S</scp>ynucleinopathies. Movement Disorders. https://doi.org/10.1002/mds.27018
388. Love, M., & Geldmacher, D. (2018). Alzheimer’s Disease. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy20
389. Lu, L. H., Reid, M., Cooper, D. B., & Kennedy, J. E. (2019). Sleep problems contribute to post-concussive symptoms in service members with a history of mild traumatic brain injury without posttraumatic stress disorder or major depressive disorder. Neurorehabilitation. https://doi.org/10.3233/nre-192702
390. Lu, S., Shaffery, J. P., Pang, Y., Tien, L., & Fan, L. (2016). Rapid Eye Movement Sleep Homeostatic Response: A Potential Marker for Early Detection of Parkinson’s Disease. Journal of Alzheimer’s Disease & Parkinsonism. https://doi.org/10.4172/2161-0460.1000255
391. Luthert, P. J., Gibb, W. R., Janota, I., & Lantos, P. L. (1989). Cortical Lewy body dementia: clinical features and classification.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.52.2.185
392. Lyden, P. D., Khalil, A., & Tidus, I. (2014). Cerebrovascular Diseases in Geriatrics. https://doi.org/10.1002/9781118730676.ch11
393. Lyketsos, C. G., López, O. L., Jones, B. N., Fitzpatrick, A. L., Breitner, J. C., & DeKosky, S. T. (2002). Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment. JAMA. https://doi.org/10.1001/jama.288.12.1475
394. Lysaker, P. H., Bryson, G., Marks, K. A., Greig, T., & Bell, M. D. (2002). Association of Obsessions and Compulsions in Schizophrenia With Neurocognition and Negative Symptoms. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.14.4.449
395. Maciag, E. J., Martín‐Noguerol, T., Ortiz-Pérez, S., Torres, C., & Luna, A. (2024). Understanding Visual Disorders through Correlation of Clinical and Radiologic Findings. Radiographics. https://doi.org/10.1148/rg.230081
396. MacQueen, G., & Young, T. M. (2003). Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders. Bipolar Disorders. https://doi.org/10.1111/j.1399-2406.2003.00059.x
397. Maddocks, I., Brew, B. J., Waddy, H., & Williams, I. (2005). Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545016.020
398. Maddocks, I., Brew, B. J., Waddy, H., & Williams, I. (2005). Problems with muscles and movement. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545016.009
399. Madhavan, D., & Kuzniecky, R. (2006). Lafora disease.. PubMed.
400. Magistris, M., & Soichot, P. (2004). [Neuropathy versus neuronopathy: distinctive features].. PubMed.
401. Mahesh, R., Pandey, D. K., Bhatt, S., & Gautam, B. (2010). Depression Associated Disorders: Comorbidity, eurobiological and eurobehavioural Link.
402. Majeske, M., Nistor, V., & Kellner, C. H. (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
403. Manquillo, A., Martinez, J., Paradinas, F., Sáez, J., Quintana, P. R., Revilla, C., López-Esteban, P., & Martínez-Galán, J. (1999). Trastorno de conducta durante el sueño MOR. Dos casos clínicos. Revista de Neurología. https://doi.org/10.33588/rn.2812.98916
404. Maranhão‐Filho, P., & Vincent, M. (2009). Neuropareidolia: diagnostic clues apropos of visual illusions. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2009000600033
405. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
406. Marino, S., Ciurleo, R., Baglieri, A., Corallo, F., De, R., De, S., Guerrera, S., Timpano, F., Bramanti, P., & Nicola, S. D. (2012). Neuroimaging and Outcome Assessment in Vegetative and Minimally Conscious State. InTech eBooks. https://doi.org/10.5772/23003
407. Martin, P., Rautenstrauβ, B., Abicht, A., Fahrbach, J., & Köster, S. (2010). Severe Myoclonic Epilepsy in Infancy – Adult Phenotype with Bradykinesia, Hypomimia, and Perseverative Behavior: Report of Five Cases. Molecular Syndromology. https://doi.org/10.1159/000326746
408. Martins, S., & Fernandes, L. (2012). Delirium in Elderly People: A Review. Frontiers in Neurology. https://doi.org/10.3389/fneur.2012.00101
409. Mashour, G. A., & Avidan, M. S. (2014). Postoperative Delirium. Anesthesiology. https://doi.org/10.1097/aln.0000000000000330
410. Mathias, C. J., & Low, D. A. (2020). Diseases of the autonomic nervous system. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0603
411. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
412. Mayo, M., & Bordelon, Y. (2014). Dementia with Lewy Bodies. Seminars in Neurology. https://doi.org/10.1055/s-0034-1381741
413. MBBS, M. M. I. (2018). Acute Confusion. https://doi.org/10.1002/9781119578055.ch44
414. McCarter, S. J., Feemster, J., Tabatabai, G., Sandness, D. J., Timm, P., McCarter, A. R., Talley, H. N., Johnson, K. L., Savica, R., Vemuri, P., Mielke, M. M., Machulda, M. M., Kantarci, K., Singer, W., Coon, E. A., Josephs, K. A., Boeve, B., Silber, M. H., & Louis, E. K. S. (2018). Diagnostic Yield of REM Sleep Muscle Activity for Presumed Synucleinopathy Neurodegeneration (N7.001). Neurology. https://doi.org/10.1212/wnl.90.15_supplement.n7.001
415. McCracken, L. M., Hindle, J. V., Bogosian, A., Robertson, N. P., Meco, G., & Hennig, E. M. (2020). Advances in Peripheral Neuropathy in Parkinson’s Disease.
416. McKay, J. H., & Cheshire, W. P. (2018). First symptoms in multiple system atrophy. Clinical Autonomic Research. https://doi.org/10.1007/s10286-017-0500-0
417. McKeith, I. G. (2000). Clinical Lewy Body Syndromes. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2000.tb06898.x
418. McKenna, D., & Peever, J. (2017). Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder. Movement Disorders. https://doi.org/10.1002/mds.27003
419. McNamara, P., Durso, R., & Auerbach, S. (2002). Dopaminergic syndromes of sleep, mood and mentation: Evidence from Parkinson's disease and related disorders. Sleep and Hypnosis.
420. McNaughton, N., & Corr, P. J. (2016). Mechanisms of comorbidity, continuity, and discontinuity in anxiety-related disorders. Development and Psychopathology. https://doi.org/10.1017/s0954579416000699
421. Meagher, D. (2012). A study of symptom profile and clinical subtypes of delirium.
422. Medrano‐Martínez, P., & Platón, M. (2016). Alteraciones cognitivas y emocionales en el insomnio crónico. Revista de Neurología. https://doi.org/10.33588/rn.6204.2015334
423. Medrano‐Martínez, P., Platón, M., & Peraita‐Adrados, R. (2018). Alteraciones neuropsicológicas en la narcolepsia con cataplejía: una revisión. Revista de Neurología. https://doi.org/10.33588/rn.6603.2017448
424. Mefford, H. C. (2016). 17q12 Recurrent Duplication.
425. Mehta, U. M., Kumar, C. N., Venkatasubramanian, G., & Thirthalli, J. (2013). Multimodal Sensory Distortions in Postpartum Exacerbation of Schizophrenia. Clinical Schizophrenia & Related Psychoses. https://doi.org/10.3371/csrp.meku.112013
426. Meijer, I. A. (2019). VPS13D Movement Disorder.
427. Melo-Dias, C., Apóstolo, J., & Cardoso, D. (2014). Effectiveness of progressive muscle relaxation training for adults diagnosed with schizophrenia: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/jbisrir-2014-1639
428. Mendez, M. F. (2001). Emergent Neuroleptic Hypersensitivity as a Herald of Presenile Dementia. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.13.3.347
429. Mendez, M. F. (2006). The Accurate Diagnosis of Early-Onset Dementia. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/q6j4-r143-p630-kw41
430. Mendez, M. F., & Lipton, A. M. (2001). Emergent Neuroleptic Hypersensitivity as a Herald of Presenile Dementia. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.13.3.347
431. Mendez, M. F., Shapira, J. S., & Saul, R. E. (2011). The Spectrum of Sociopathy in Dementia. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.23.2.132
432. Mendez, M. F., Shapira, J., & Saul, R. E. (2011). The Spectrum of Sociopathy in Dementia. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.23.2.jnp132
433. Mengel, E., Klünemann, H.-H., Lourenço, C. M., Hendriksz, C. J., Sedel, F., Walterfang, M., & Kolb, S. (2013). Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-8-166
434. Merkli, H., Pál, E., Gati, I., Kosztolányi, P., & Kövér, F. (2004). [Early onset dementias: three cases].. PubMed.
435. Mervis, C. Β., Morris, C. A., Klein-Tasman, B., Velleman, S. L., & Osborne, L. R. (2015). 7q11.23 Duplication Syndrome.
436. Metz-Lutz, D. M.-N., Martin, A. D. S., & Ponsot, G. (2003). Continuous spike-and-wave discharges during slow sleep.
437. Mihaljević-Peleš, A., Janović, M. B., Šagud, M., Živković, M., Janović, Š., & Jevtović, S. (2019). Cognitive deficit in schizophrenia: an overview.. PubMed.
438. Miller, A., DeAngelis, T. M., Fabian, M., & Sand, I. K. (2018). A Case of Myelitis with a Positive Anticardiolipin Antibody. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190693190.003.0004
439. Miller, S. P., & Latal, B. (2009). Neurocognitive outcomes of term infants with perinatal asphyxia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581281.050
440. Millin, M. G., Shah, S. M., & Wright, D. G. (2003). Nontraumatic Spinal Cord Emergencies. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.027
441. Minton, C. A. B., Bruner, S. M., & Morris, C. A. W. (2017). Diagnosis and Treatment of Children and Adolescents. Routledge eBooks. https://doi.org/10.4324/9781315466736-15
442. Mishima, K., Okawa, M., Hozumi, S., & Hishikawa, Y. (2000). SUPPLEMENTARY ADMINISTRATION OF ARTIFICIAL BRIGHT LIGHT AND MELATONIN AS POTENT TREATMENT FOR DISORGANIZED CIRCADIAN REST-ACTIVITY AND DYSFUNCTIONAL AUTONOMIC AND NEUROENDOCRINE SYSTEMS IN INSTITUTIONALIZED DEMENTED ELDERLY PERSONS. Chronobiology International. https://doi.org/10.1081/cbi-100101055
443. Mizuno, Y. (1997). [Concept and diagnostic criteria of Parkinson's disease and parkinsonism].. PubMed.
444. Mollenhauer, B., & Weintraub, D. (2017). The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1700737114
445. Mondon, K., Bonnaud, I., Debiais, S., Brunault, P., Saudeau, D., Toffol, B. D., & Autret, A. (2007). Abrupt onset of disturbed vigilance, bilateral third nerve palsy and masturbating behaviour: a rare presentation of stroke. Emergency Medicine Journal. https://doi.org/10.1136/emj.2007.047662
446. Moore, D. P., & Puri, B. K. (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E.
447. Morales‐Briceño, H., Cervantes‐Arriaga, A., & Rodríguez‐Violante, M. (2011). [Premotor diagnosis of Parkinson's disease].. Gaceta Médica de México.
448. Morin, C. (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
449. Moro‐de‐Casillas, M. L., & Riley, D. E. (2012). Insomnia in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_17
450. Mosimann, U. P., & McKeith, I. G. (2003). Dementia with lewy bodies - diagnosis and treatment. Schweizerische medizinische Wochenschrift. https://doi.org/10.4414/smw.2003.10028
451. Mott, T., McConnon, M. L., & Rieger, B. (2012). Subacute to chronic mild traumatic brain injury.. PubMed.
452. Mucha, B. E., Hennekam, R. C. M., Sisodiya, S. M., & Campeau, P. M. (2015). TBC1D24-Related Disorders.
453. Mudey, R. P., & Hullumani, V. S. (2024). Rare Clinical Image of Kennedy’s Syndrome. Neurology India. https://doi.org/10.4103/neurol-india.neurol-india-d-24-00196
454. Munawar, M., Iftikhar, P. M., Khan, J. A., Syed, N. A., & Syed, T. A. (2019). A Case Report of Seronegative Limbic Encephalitis. Cureus. https://doi.org/10.7759/cureus.4681
455. Murphy, D. L., Timpano, K. R., Wheaton, M. G., Greenberg, B. D., & Miguel, E. C. (2010). Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2010.12.2/dmurphy
456. Murueta‐Goyena, A., Andikoetxea, A., Gómez‐Esteban, J. C., & Gabilondo, I. (2019). Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s Disease. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.01294
457. Muscat, W., & Assuras, S. (2024). A - 110 Characterization of Mild Cognitive Impairment in Multiple System Atrophy. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acae067.124
458. Muthusamy, P., Matte, G., Kosmorsky, G. S., & Chémali, K. R. (2011). Chiari Type I Malformation. The Neurologist. https://doi.org/10.1097/nrl.0b013e3181f83870
459. Méndez, M., & Radtke, R. A. (2001). Interactions Between Sleep and Epilepsy. Journal of Clinical Neurophysiology. https://doi.org/10.1097/00004691-200103000-00003
460. Möller, C., Lyxell, B., Henricson, C., & Frölander, H.-E. (2013). Different deafblind syndromes and cognitive function : Geno-phenotype correlations and/or sensory deprivation.
461. Na, S., Hong, Y. J., Kim, S., & Lee, E. (2025). Dizziness and neuro-otologic findings in neurodegenerative disorders: a review. Research in Vestibular Science. https://doi.org/10.21790/rvs.2024.026
462. Nabi, S. U., Dey, S., Gupta, G., Kumar, A., Vala, J., & Jan, M. H. (2010). A study of neuromuscular dysfunctions in geriatric dogs.. Haryana Veterinarian.
463. Nakamura, M., Tanaka, S., Inoue, T., Maeda, Y., Okumiya, K., Esaki, T., Shimomura, G., Masunaga, K., Nagamitsu, S., & Yamashita, Y. (2017). Systemic Lupus Erythematosus and Sjögren’s Syndrome Complicated by Conversion Disorder: a Case Report. The Kurume Medical Journal. https://doi.org/10.2739/kurumemedj.ms644005
464. Nassisi, D., Korc, B., Hahn, S. A., Bruns, J., & Jagoda, A. (2006). The evaluation and management of the acutely agitated elderly patient.. PubMed.
465. Nastasić, P. (2012). Addiction: Therapeutic possibilities and clinical reality. Arhiv za farmaciju.
466. Nedelská, Z., Boeve, B. F., Ferman, T. J., Senjem, M. L., Przybelski, S. A., Lesnick, T. G., Knopman, D. S., Graff‐Radford, J., Jones, D. T., Savica, R., Drubach, D. A., Fields, J. A., Graff‐Radford, N. R., Lowe, V. J., Jack, C. R., Petersen, R. C., & Kantarci, K. (2019). P3‐427: MILD COGNITIVE IMPAIRMENT PROGRESSING TO DEMENTIA WITH LEWY BODIES: REGIONAL ATROPHY RATES AND RELATIONSHIP TO AV‐1451 UPTAKE. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2019.06.3461
467. Nesteruk, M., Nesteruk, T., Ułamek-Kozioł, M., Holak-Puczyńska, A., & Dorobek, M. (2019). Creutzfeldt-Jakob disease mimicking Lewy body dementia – a case report. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/110915
468. Neubauer, B. A., Doose, H., & Petersen, B. (2000). The concept of hereditary impairment of brain maturation.. PubMed.
469. Neurodegenerative, D. Y., Billiard, M., & Dauvilliers, Y. (2003). Neurodegenerative diseases and sleep disorders. Schweizer Archiv für Neurologie und Psychiatrie. https://doi.org/10.4414/sanp.2003.01418
470. Nia, K. S., Rahmani, F., Bakhtavar, H. E., Aghdam, A. A. T., Sadeghi‐Hokmabadi, E., & Massood, A. (2014). Sudden Visual Loss in Patient Suspected Diagnosis of Multiple Sclerosis. Journal of Arak University of Medical Sciences.
471. Nielsen, J. F., Klemar, B., Hansen, H., & Sinkjær, T. (1995). A new treatment of spasticity with repetitive magnetic stimulation in multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.58.2.254-a
472. Niemeyer, G. (1999). Vom Symptom zur Elektroretinographie-Diagnose. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/s-2008-1034806
473. Nikpour, S. (2012). Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review.. PubMed.
474. Nițescu, D., Nicolau, A., Caraiola, S., Predețeanu, D., Ionescu, R., & Tănăsescu, C. (2011). Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?. PubMed.
475. O'Bryan, R. A., Brenner, C. A., Hetrick, W. P., & O’Donnell, B. F. (2014). Disturbances of visual motion perception in bipolar disorder. Bipolar Disorders. https://doi.org/10.1111/bdi.12173
476. Oertel, W. H., Vadász, D., Ries, V., Mayer, G., Eggert, K., Krenzer, M., Unger, M. M., Höglinger, G. U., Mollenhauer, B., Sixel-Döring, F., Trenkwalder, C., & Depboylu, C. (2013). Prodromale Marker der Parkinson-Krankheit. Aktuelle Neurologie. https://doi.org/10.1055/s-0033-1355379
477. Ogata, T., Sakakibara, R., Tateno, F., Tsuyusaki, Y., Tateno, H., Aiba, Y., Kishi, M., Inaoka, T., Terada, H., Doi, H., & Suzuki, Y. (2016). Mild Cognitive Impairment as the Initial Manifestation of Progressive Supranuclear Palsy. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.14001
478. Oleksy, B., Mierzewska, H., Lipiec, A., & Szczepanik, E. (2020). Why should a neuropaediatrician always measure head circumference - a case report of Glucose transporter 1 deficiency syndrome (Glut1-DS). Child Neurology. https://doi.org/10.20966/chn.2020.58.464
479. Oreja‐Guevara, C., Blanco, T. A., Brieva, L., Pérez, M. Á. H., Meca‐Lallana, V., & Ramió‐Torrentà, L. (2019). Cognitive Dysfunctions and Assessments in Multiple Sclerosis. Frontiers in Neurology. https://doi.org/10.3389/fneur.2019.00581
480. Orozco, E., Guo, Y., Chen, J. J., Dubey, D., Howell, B., Moutvic, M. A., Louis, E. K. S., & McKeon, A. (2022). Clinical Reasoning: A 43-Year-Old Man With Subacute Onset of Vision Disturbances, Jaw Spasms, and Balance and Sleep Difficulties. Neurology. https://doi.org/10.1212/wnl.0000000000200950
481. Ospina, B., & Vélez, J. L. O. (2019). Espectro clínico y tratamiento del trastorno cognoscitivo y demencia asociada a la enfermedad de Parkinson. Acta neurológica colombiana. https://doi.org/10.22379/24224022248
482. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
483. O’Brien, M. D. (2017). The Neurological Examination: Aeromedical Considerations. CRC Press eBooks. https://doi.org/10.1201/9781315238166-9
484. O’Donnell, B. F. (2007). Cognitive Impairment in Schizophrenia: A Life Span Perspective. American Journal of Alzheimer s Disease & Other Dementias®. https://doi.org/10.1177/1533317507304745
485. Padmos, R. C. (2009). Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases.
486. Pagel, J. (2008). Sleep and dreaming – medication effects and side-effects. CRC Press eBooks. https://doi.org/10.3109/9780203091715-59
487. Palagini, L., & Gemignani, A. (2012). Significance of REM Sleep in Depression: Effects on Neurogenesis. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000e109
488. Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S. (2018). Cognitive impairment in major depressive disorder. CNS Spectrums. https://doi.org/10.1017/s1092852918001207
489. Pandit, M. S., Gupta, A., Mathur, P., Sharma, M., & Garg, M. (2016). JOURNAL OF PEDIATRIC CRITICAL CARE. JOURNAL OF PEDIATRIC CRITICAL CARE. https://doi.org/10.21304/2016.0302.00123
490. Panfilova, E., Bobylova, M. Y., Kapustina, A. A., Braudo, T. A., Abramov, M. O., & Klepikov, N. I. (2017). Motor and sensory alalia: diagnostic difficulties. Russian Journal of Child Neurology. https://doi.org/10.17650/2073-8803-2017-12-4-32-42
491. Papageorgopoulou, E., & Jones, E. J. H. (2025). Infant Precursors to Autism. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.55
492. Paprocka, J., Jamroz, E., Szwed-Białożyt, B., Jezela‐Stanek, A., Kopyta, I., & Marszał, E. (2007). Angelman Syndrome Revisited. The Neurologist. https://doi.org/10.1097/01.nrl.0000253067.32759.aa
493. Parida, S., Pandey, N., Kumar, A., Singh, V. K., Dhiman, N. R., Srivastava, N. K., & Joshi, D. (2025). An interesting case of subacute sclerosing panencephalitis presenting with Balint’s syndrome and dysautonomia. encephalitis. https://doi.org/10.47936/encephalitis.2024.00115
494. Parker, R. S. (2012). Chronic Posttraumatic Disorders of Consciousness. CRC Press eBooks. https://doi.org/10.1201/b10562-14
495. Patti, L., & Gupta, M. (2019). Change In Mental Status. StatPearls.
496. Paz, T. D. S. R., Silva, A. E. L., Martins, N. I. M., Brito, V. L. S. D., Leite, M. A. A., & Corrêa, C. L. (2019). Congelamento da marcha e de membros superiores na doença de Parkinson. Revista Brasileira de Neurologia.
497. Peall, K. J., Kuiper, A., Koning, T. D., & Tijssen, M. A. (2014). REVIEW: NON-MOTOR SYMPTOMS IN DYSTONIA-PLUS DISORDERS. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2014-309236.202
498. Peller, P. J., Hunt, C. H., & Johnson, G. B. (2011). FDG PET/CT brain imaging in atypical parkinsonian disorders: A pictorial guide with MRI correlation.
499. Pennisi, M., Bramanti, A., Cantone, M., Pennisi, G., Bella, R., & Lanza, G. (2017). Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2017.00498
500. Peralta, C. (2013). [Neuropsychiatric non motor symptoms of Parkinson's disease].. PubMed.
501. Peretti, C.-S., Ferreri, F., & Crucis, B. (2009). Troubles cognitifs dans la dépression. La Lettre du psychiatre.
502. Peron, A., Bradbury, K., Viskochil, D., & Dias, C. (2019). BCL11A-Related Intellectual Disability.
503. Perry, E. K., Kerwin, J., Perry, R. H., Irving, D., Blessed, G., & Fairbairn, A. (1990). Cerebral Cholinergic Activity Is Related to the Incidence of Visual Hallucinations in Senile Dementia of Lewy Body Type. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000107114
504. Pesantez-Rios, G., Martínez-Bermejo, A., & Pesantez-Cuesta, G. (2016). Las alteraciones neuropsicológicas son frecuentes en la epilepsia rolándica y sus evoluciones atípicas. Revista de Neurología. https://doi.org/10.33588/rn.6303.2016004
505. PIa, K., Mg, D., Mi, K., & Si, M. (2006). [Diagnostic value of particularities of circadian rhythms of sleep-wake cycle in early ontogenesis]..
506. Piano, M., Nilforooshan, R., & Evans, S. (2019). Binocular Vision, Visual Function, and Pupil Dynamics in People Living With Dementia and Their Relation to the Rate of Cognitive Decline and Structural Changes Within the Brain: Protocol for an Observational Study (Preprint). https://doi.org/10.2196/preprints.16089
507. Picard, L. S., Lindsay, S., Strawn, J. R., Kaneria, R. M., Patel, N. C., & Keck, P. E. (2008). Atypical Neuroleptic Malignant Syndrome: Diagnostic Controversies and Considerations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.28.4.530
508. Polanowska, K., & Seniów, J. (2005). [Motor variant of the unilateral neglect syndrome as a consequence of brain injury].. PubMed.
509. Polanowska, K., & Seniów, J. (2005). Obraz kliniczny i diagnostyka zespołu zaniedbywania jednostronnego.
510. Poletti, M., & Bonuccelli, U. (2011). From Narcissistic Personality Disorder to Frontotemporal Dementia: A Case Report. Behavioural Neurology. https://doi.org/10.1155/2011/328962
511. Poletti, M., & Bonuccelli, U. (2011). From narcissistic personality disorder to frontotemporal dementia: a case report.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.3233/ben-2011-0326
512. Poletti, M., Frosini, D., Pagni, C., Baldacci, F., Giuntini, M., Mazzucchi, S., Tognoni, G., Lucetti, C., Dotto, P. D., Ceravolo, R., & Bonuccelli, U. (2012). The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2012.751966
513. Poley, E. B. (2003). El insomnio en la infancia. Revista de Neurología. https://doi.org/10.33588/rn.3604.2002229
514. Postuma, R. B., & Walker, Z. (2017). Dementia with Lewy bodies. Neurology. https://doi.org/10.1212/wnl.0000000000004163
515. Postuma, R. B., Aarsland, D., Barone, P., Burn, D. J., Hawkes, C. H., Oertel, W. H., & Ziemssen, T. (2012). Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.24996
516. Potvin, S., Stavro, K., & Pelletier, J. (2012). Paradoxical Cognitive Capacities in Dual Diagnosis Schizophrenia: The Quest for Explanatory Factors. Journal of Dual Diagnosis. https://doi.org/10.1080/15504263.2012.648549
517. Pradnyawati, M. A. D., Ratep, N., & Westa, W. (2014). DELIRIUM PADA PASIEN RAWAT INAP DENGAN SKIZOFRENIA: SEBUAH LAPORAN KASUS. E-Jurnal Medika Udayana.
518. Prakash, R., Pathak, A., Munda, S. K., & Bagati, D. (2009). Quetiapine Effective in Treatment of Inappropriate Sexual Behavior of Lewy Body Disease With Predominant Frontal Lobe Signs. American Journal of Alzheimer s Disease & Other Dementias®. https://doi.org/10.1177/1533317508329479
519. Prather, P., & Vries, P. J. D. (2004). Behavioral and Cognitive Aspects of Tuberous Sclerosis Complex. Journal of Child Neurology. https://doi.org/10.1177/08830738040190090601
520. Pratibha, S. (2010). Etiology of Late Onset Seizures.
521. Presečki, P., Filipčić, I., Arbanas, G., & Mimica, N. (2014). Neurocognitive disorders in DSM-5.
522. Pugliese, M., Rossi, C., Guidotti, I., Gallo, C., Casa, E. D., Bertoncelli, N., Coccolini, E., & Ferrari, F. (2013). Preterm birth and developmental problems in infancy and preschool age Part II: cognitive, neuropsychological and behavioural outcomes. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.3109/14767058.2013.794205
523. Pérez-Lloret, S., & Barrantes, F. J. (2016). Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. npj Parkinson s Disease. https://doi.org/10.1038/npjparkd.2016.1
524. Rachdi, A., Dupouy, J., Bénaiteau, M., Bost, C., Moreau, M. S., Courbon, C. B., Rascol, O., & Magne, F. O. (2019). Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.477
525. Radmanović, M. B., & Burgić, S.-S. (2020). Comorbidity in Children and Adolescents with ADHD. IntechOpen eBooks. https://doi.org/10.5772/intechopen.94527
526. Rahman, S., Footitt, E., Varadkar, S., & Clayton, P. T. (2012). Inborn errors of metabolism causing epilepsy. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2012.04406.x
527. Ramnani, V., Ramnani, S., Trivedi, D., Deo, P., & Jain, R. (2025). Posterior Reversible Encephalopathy Syndrome: The Eyes Reflecting Systemic Health. Cureus. https://doi.org/10.7759/cureus.82754
528. Rao, N., & Suhas, S. (2019). Neurocognitive deficits in obsessive–compulsive disorder: A selective review. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_517_18
529. Rao, S. C., & Silber, M. H. (2001). Sleep-related hallucinationsand exploding head syndrome. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511711947.022
530. Rapin, I., Weidenheim, K. M., Lindenbaum, Y., Rosenbaum, P. S., Merchant, S. N., Krishna, S., & Dickson, D. W. (2006). Cockayne Syndrome in Adults: Review With Clinical and Pathologic Study of a New Case. Journal of Child Neurology. https://doi.org/10.1177/08830738060210110101
531. Ratai, E., Caruso, P. A., & Eichler, F. (2012). Advances in MR Imaging of Leukodystrophies. InTech eBooks. https://doi.org/10.5772/25151
532. Rathod, B., Kaur, A., Basavanagowda, D. M., Mohan, D., Mishra, N., Fuad, S., Nosher, S., Alrashid, Z. A., & Heindl, S. E. (2020). Neurological Soft Signs and Brain Abnormalities in Schizophrenia: A Literature Review. Cureus. https://doi.org/10.7759/cureus.11050
533. Raut, T., Singh, M. K., Garg, R. K., & Rai, D. (2012). Evolution of certain typical and atypical features in a case of subacute sclerosing panencephalitis. BMJ Case Reports. https://doi.org/10.1136/bcr-2012-007052
534. Razmeh, S., Almasi‐Dooghaee, M., Habibi, S. A. H., & Alizadeh, E. (2016). Rapidly progressive dementia and unilateral jerky movements: a case of Creutzfeldt-Jakob disease. Postgraduate Medical Journal. https://doi.org/10.1136/postgradmedj-2016-134178
535. Reckel, L. D. O., Coser, J. A. C., Cezana, D. F., Machado, L. D. B., Bicalho, F. F., Morau, E., Silva, G. B. E., Simões, I. G., Oliveira, I. F. D., & Novaes, L. M. C. D. (2023). SÍNDROME DE KLEINE-LEVIN. Revista Multidisciplinar em Saúde. https://doi.org/10.51161/integrar/rems/3893
536. Reed, U. C., Marie, S. K. N., Vainzof, M., Gobbo, L. F., Gurgel, J., Carvalho, M. S., Resende, M. B. D. D., Espíndola, A. Á. D., Zatz, M., & Diament, A. J. (2000). Heterogeneity of Classic Congenital Muscular Dystrophy With Involvement of the Central Nervous System: Report of Five Atypical Cases. Journal of Child Neurology. https://doi.org/10.1177/088307380001500306
537. Reijnders, M. R., Leventer, R. J., Lee, B. H., Baralle, D., Selber, P., Paciorkowski, A. R., & Hunt, D. (2017). PURA-Related Neurodevelopmental Disorders. University of Washington, Seattle eBooks.
538. Reimers, K., Emmert, N. A., Shah, H., Benedict, R. H. B., & Szigeti, K. (2014). Capgras-like visual decomposition in Lewy body dementia with therapeutic response to donepezil. Neurology Clinical Practice. https://doi.org/10.1212/cpj.0000000000000068
539. Reischies, F. M., & Mentzel, A. (2001). Neuropsychological Deficits of Acute Schizophrenic Patients Without Neuroleptic Medication. Zeitschrift für Neuropsychologie. https://doi.org/10.1024//1016-264x.12.1.42
540. Rengel, K. F., Hayhurst, C. J., Pandharipande, P. P., & Hughes, C. G. (2019). Long-term Cognitive and Functional Impairments After Critical Illness. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000004066
541. Renger, J. J. (2008). Overview of Experimental and Conventional Pharmacological Approaches in the Treatment of Sleep and Wake Disorders. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/156802608784936755
542. Reuter, I., Mehnert, S., Oechsner, M., & Engelhardt, M. (2011). Cognitive Rehabilitation in Parkinson's Disease Using Neuropsychological Training, Transfer Training and Sports Therapy. InTech eBooks. https://doi.org/10.5772/17685
543. Ricci, S., Cusmai, R., Fusco, L., & Vigevano, F. (1995). Reflex Myoclonic Epilepsy in Infancy: A New Age‐Dependent Idiopathic Epileptic Syndrome Related to Startle Reaction. Epilepsia. https://doi.org/10.1111/j.1528-1157.1995.tb01007.x
544. Rigolet, M., Aouizerate, J., Couette, M., Ragunathan-Thangarajah, N., Aoun-Sebaïti, M., Gherardi, R. K., Cadusseau, J., & Authier, F. (2014). Clinical Features in Patients with Long-Lasting Macrophagic Myofasciitis. Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00230
545. Riordan, S. M., & Williams, R. R. (2010). Gut Flora and Hepatic Encephalopathy in Patients with Cirrhosis. New England Journal of Medicine. https://doi.org/10.1056/nejme1000850
546. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
547. Rizvi, S. Z. H., Palimar, V., Gupta, C., & Andrade, L. S. (2024). Spectrum of Non-Motor Symptoms in Parkinson’s Disease — a Review. Annals of Clinical and Experimental Neurology. https://doi.org/10.17816/acen.1001
548. Robaj, A., & Shabani, E. (2019). Hypothetical Radiological Findings in Dogs and Cats Suffering from Insomnia. International Journal of Innovative Approaches in Agricultural Research. https://doi.org/10.29329/ijiaar.2019.206.18
549. Roger, J. (2005). Epileptic Syndromes in Infancy, Childhood and Adolescence.
550. Rohilla, J., & Tak, P. (2016). DIAGNOSTIC DIFFICULTIES IN A PATIENT WITH HUNTINGTON DISEASE WITH SCHIZOPHRENIA LIKE PSYCHOSIS - A CASE REPORT. Asean Journal of Psychiatry.
551. Rojas‐Fernandez, C., & MacKnight, C. (1999). Dementia with Lewy Bodies: Review and Pharmacotherapeutic Implications. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.19.10.795.31555
552. Rolinski, M., & Ebmeier, K. P. (2011). Tackling dementia in patients with Parkinson's disease..
553. Ronco, C., McCullough, P. A., Anker, S. D., Anand, I. S., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., Daliento, L., Davenport, A., Haapio, M., Hillege, H. L., House, A. A., Katz, N., Maisel, A. S., Mankad, S., Zanco, P., ... Ponikowski, P. (2010). Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contributions to nephrology. https://doi.org/10.1159/000313745
554. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
555. Rozzini, L., Chilovi, B. V., Conti, M. Z., Delrio, I., Borroni, B., Trabucchi, M., & Padovani, A. (2007). Neuropsychiatric Symptoms in Amnestic and Nonamnestic Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000111133
556. Rościszewska-Żukowska, I., & Bartosik-Psujek, H. (2020). Demyelinating or hereditary optic neuropathy? Comparison of selected disease entities. Aktualności Neurologiczne. https://doi.org/10.15557/an.2020.0011
557. Rubboli, G., Franceschetti, S., Berkovic, S. F., Canafoglia, L., Gambardella, A., Dibbens, L. M., Riguzzi, P., Campieri, C., Magaudda, A., Tassinari, C. A., & Michelucci, R. (2011). Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by<i>SCARB2</i>mutations. Epilepsia. https://doi.org/10.1111/j.1528-1167.2011.03307.x
558. Rubboli, G., Huber, R., Tononi, G., & Tassinari, C. A. (2019). Encephalopathy related to Status Epilepticus during slow Sleep: a link with sleep homeostasis?. Epileptic Disorders. https://doi.org/10.1684/epd.2019.1059
559. Rubino, F. A. (2002). Gait Disorders. The Neurologist. https://doi.org/10.1097/00127893-200207000-00005
560. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
561. Ruff, R. M., Silver, C., Iverson, G. L., BARTH, J., BROSHEK, D., Bush, S. B., Koffler, S. P., & Reynolds, C. W. (2007). Learning disabilities: The need for neuropsychological evaluation. Archives of Clinical Neuropsychology. https://doi.org/10.1016/j.acn.2007.09.006
562. Ryan, M. M. (2011). Neurological disorders affecting the lower limb in children. Journal of Foot and Ankle Research. https://doi.org/10.1186/1757-1146-4-s1-i10
563. Saito, Y., & Murayama, S. (2012). [Braak's hypothesis and non-motor symptoms of Parkinson disease].. PubMed.
564. Salacz, P., Hidasi, Z., & Csibri, É. (2011). Neurological symptoms in psychiatry. Neuropsychopharmacologia Hungarica. https://doi.org/10.5706/nph201109003
565. Samra, K. A. (2012). The eye and visual system in the preeclampsia/eclampsia syndrome: What to expect?. Saudi Journal of Ophthalmology. https://doi.org/10.1016/j.sjopt.2012.04.003
566. Sans, A., Colomé, R., López‐Sala, A., Boix, C. M., Muchart, J., Rebollo, M., Guitet, M., Callejón-Póo, L., & Campistol, J. (2011). Developmental amnesia as a focal cognitive sequela of a neonatal pathology.
567. Saunders‐Pullman, R., Raymond, D., & Elango, S. (2019). LRRK2 Parkinson Disease.
568. Savica, R., Rocca, W. A., & Ahlskog, J. E. (2010). When Does Parkinson Disease Start?. Archives of Neurology. https://doi.org/10.1001/archneurol.2010.135
569. Sc, D., Mj, W., Hh, K.-L., Houten, V., & Eurelings, M. (2014). [Concentration problem or epilepsy? Sudden changes in behaviour in adolescents].. PubMed.
570. Schaun, D. V. S. L., Pallone, E., Oliveira, G., Souza, H. P. D., Dias, L. L., Thomaz, M. S., Marchesani, J. L. W. C., Ferreira, I. G., Araújo, V., & Miranda, L. F. J. R. D. (2025). Diagnosis and management of corticobasal syndrome in a phenotypic presentation of Parkinson's Disease. Revista Eletrônica Acervo Saúde. https://doi.org/10.25248/reas.e20755.2025
571. Schenck, C. H. (1987). Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA. https://doi.org/10.1001/jama.257.13.1786
572. Schildkrout, B. (2011). Characteristics That Make Somatic Diseases Difficult to Detect. https://doi.org/10.1002/9781118083598.ch3
573. Schildkrout, B. (2011). Specific Physical Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch7
574. Schlachetzki, J. C. M. (2011). Frontotemporal Lobar Degeneration. InTech eBooks. https://doi.org/10.5772/28174
575. Schlotawa, L., Adang, L., Castro, M. D., & Ahrens‐Nicklas, R. C. (2019). Multiple Sulfatase Deficiency.
576. Scott, B. M., & Benge, J. F. (2024). Lewy Body Disease and Atypical Parkinsonian Conditions. Dementia. https://doi.org/10.1093/med/9780197690024.003.0012
577. Scott, D. A., & Sherr, E. H. (2019). RERE-Related Disorders.
578. Seichepine, D. R., Neargarder, S., Miller, I. N., Riedel, T. M., Gilmore, G. C., & Cronin‐Golomb, A. (2011). Relation of Parkinson's Disease Subtypes to Visual Activities of Daily Living. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617711000853
579. Seltzer, L. E., & Scher, M. S. (2014). Neonatal seizures in the era of therapeutic hypothermia. Neurology. https://doi.org/10.1212/wnl.0000000000000297
580. Sen, A., & Johnson, M. R. (2020). Epilepsy in later childhood and adulthood. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0575
581. Seo, J.-G., Park, S.-P., & Lee, H. (2014). Sleep Disorders in Neurodegenerative Disorders. Journal of Korean Sleep Research Society. https://doi.org/10.13078/jksrs.14001
582. Seppi, K., & Rascol, O. (2007). Dementia with Lewy bodies and Parkinson disease with dementia. Neurology. https://doi.org/10.1212/01.wnl.0000269667.17041.66
583. Sethi, K. D. (2002). Clinical aspects of Parkinson disease. Current Opinion in Neurology. https://doi.org/10.1097/00019052-200208000-00009
584. Sethi, K. D. (2003). Clinical aspects of Parkinson disease. Current Opinion in Internal Medicine. https://doi.org/10.1097/00132980-200302010-00004
585. Sethi, K. D., & Mehta, S. H. (2012). A clinical primer on restless legs syndrome: what we know, and what we don't know.. PubMed.
586. Sezgi̇n, M., Bılgıç, B., Tinaz, S., & Emre, M. (2019). Parkinson's Disease Dementia and Lewy Body Disease. Seminars in Neurology. https://doi.org/10.1055/s-0039-1678579
587. Shah, V., Coussa, R. G., & Traboulsi, E. I. (2025). Hereditary Optic Neuropathies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197659403.003.0043
588. Shahar, A. M., Ngiu, C. S., Hashim, H. Z., Tan, H. J., & Periyasamy, P. (2011). No Coma, but Expressive Dysphasia with Cerebellar Signs: An Unique Presentation of Cerebral Malaria. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.v40n8p382
589. Shamiya, M., & Hardin, K. A. (2018). 1097 Pathologic Lucid Dreams in a Patient with Fibromyalgia: A Case Report. SLEEP. https://doi.org/10.1093/sleep/zsy063.1096
590. Sharifian, M., Khalili, M. R., Nomovi, M., & Dorche, A. S. (2017). Leber Hereditary Optic Neuropathy Plus: A Case Report and Review of Literatures. Internal Medicine And Medical Investigation Journal. https://doi.org/10.24200/imminv.v2i3.67
591. Sharma, N., & Kolekar, H. M. (2017). Diagnosis of Vascular Cognitive Impairment Using EEG. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2017.00454.5
592. Sharma, S., Sharma, N., & Yeolekar, M. (2011). An Adolescent Boy with Acquired Epileptic Aphasia - Landau Kleffner Syndrome: A rare case report. Journal of Nepal Paediatric Society. https://doi.org/10.3126/jnps.v31i1.3543
593. Sheikh, M., & Galvin, J. E. (2018). Neurocognitive Disorders With Lewy Bodies. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy21
594. Sheppard, E., & Lippé, S. (2012). Cognitive Outcome of Status Epilepticus in Children. Epilepsy Research and Treatment. https://doi.org/10.1155/2012/984124
595. Shiari, R., Yegane, M. H., Farivar, S., Parvaneh, V. J., & Mirjavadi, S. A. (2014). Neuropsychiatric Symptoms as The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case with Klinefelter's Syndrome.. PubMed.
596. Shibasaki, H., & Hallett, M. (2016). Psychogenic Neurologic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190240974.003.0026
597. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Sleep-Related Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0008
598. Shin, H., Kim, S. H., Lee, M. Y., Yoon, S. A., Kim, S. Y., & Lee, Y. C. (2017). Sudden bilateral vision loss as the sole manifestation of posterior reversible encephalopathy syndrome from acute uremia. Medicine. https://doi.org/10.1097/md.0000000000007424
599. Shkrobot, S. (2025). Atypical forms of motor neuron disease: a review of the problem and clinical cases. INTERNATIONAL NEUROLOGICAL JOURNAL. https://doi.org/10.22141/2224-0713.21.5.2025.1206
600. Shorvon, S. (1987). Intensive Neurodiagnostic Monitoring. (Advances in Neurology Vol 46).. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.50.9.1247-a
601. Shorvon, S. (2012). The Causes of Epilepsy. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199659043.003.0006
602. Shu-yin, G. (2009). Atyptical Guillain-Barre Syndrome case analysis(attaches 4 example reports). Journal of Brain and Nervous Diseases.
603. Silber, M. H. (2020). Parasomnias Occurring in Non–Rapid Eye Movement Sleep. CONTINUUM Lifelong Learning in Neurology. https://doi.org/10.1212/con.0000000000000877
604. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
605. Silva, N. D., Singhapathirana, S., & Silva, C. E. D. (2019). Miller Fisher Syndrome presenting as unilateral abducens nerve palsy: A case report. Research Square (Research Square). https://doi.org/10.21203/rs.2.9144/v1
606. Silverberg, N. D., & Rush, B. (2023). Neuropsychological evaluation of functional cognitive disorder: A narrative review. The Clinical Neuropsychologist. https://doi.org/10.1080/13854046.2023.2228527
607. Sinclair, K. (2017). Fatigue and sleep disturbance following traumatic brain injury: A role for light therapy?. https://doi.org/10.4225/03/5897ea5407f6e
608. Skraban, C., Grand, K., & Deardorff, M. A. (2019). WDR26-Related Intellectual Disability.
609. Small, G. A., & Chuirazzi, D. M. (2003). Weakness. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.008
610. Smeets, P. A., Laverdeur, J., Jedidi, Z., Jedidi, H., & Depierreux, F. (2024). [Senses and dementia : sensory loss and dementia risk].. PubMed.
611. Smith, T. E., Hull, J. W., ISRAEL, L. M., & Willson, D. F. (2000). Insight, Symptoms, and Neurocognition in Schizophrenia and Schizoaffective Disorder. Schizophrenia Bulletin. https://doi.org/10.1093/oxfordjournals.schbul.a033439
612. Solas, G., Bustamante, P., & Grandez, K. (2011). Neurodegenerative Disease Monitoring Using a Portable Wireless Sensor Device. InTech eBooks. https://doi.org/10.5772/29814
613. Solhaug, M. J., Bolger, P. M., & José, P. A. (2004). The Developing Kidney and Environmental Toxins. PEDIATRICS. https://doi.org/10.1542/peds.113.s3.1084
614. Solhaug, M. J., Bolger, P. M., & José, P. A. (2004). The developing kidney and environmental toxins.. PubMed.
615. Solorzano, J. M. M., Quijije, J. K. L., Pin, T. D. R. M., & Vera, J. V. C. (2020). Causas y efectos de los pacientes diagnosticados con el mal de Parkinson. RECIMUNDO. https://doi.org/10.26820/recimundo/4.(4).octubre.2020.496-508
616. Sonnen, J. A., Keene, C. D., Hevner, R. F., & Montine, T. J. (2009). Molecular Pathology: Neuropathology. Molecular Pathology. https://doi.org/10.1016/b978-0-12-374419-7.00027-5
617. Sosso, F. A. E., Nakamura, O., & Nakamura, M. (2017). Evaluation of Combined Effects of Insomnia and Stress on Sleep Quality and Sleep Duration. Journal of Neurology and Neuroscience. https://doi.org/10.21767/2171-6625.1000202
618. Spira, A. P., Friedman, L., Aulakh, J. S., Lee, T., Sheikh, J. I., & Yesavage, J. A. (2008). Subclinical Anxiety Symptoms, Sleep, and Daytime Dysfunction in Older Adults With Primary Insomnia. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988707317120
619. Sreedhar, A., & Menon, A. (2019). Understanding and evaluating diplopia. Kerala Journal of Ophthalmology. https://doi.org/10.4103/kjo.kjo_57_19
620. Sringean, J. (2024). Sleep and circadian rhythm dysfunctions in movement disorders beyond Parkinson's disease and atypical parkinsonisms. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000001286
621. Sringean, J., Udomsirithamrong, O., & Bhidayasiri, R. (2024). Too little or too much nocturnal movements in Parkinson’s disease: A practical guide to managing the unseen. Clinical Parkinsonism & Related Disorders. https://doi.org/10.1016/j.prdoa.2024.100258
622. Srivastav, M. (2014). Causes of Hypersomnia – Narcolepsy. DOAJ (DOAJ: Directory of Open Access Journals).
623. Stamenović, J., Đurić, S., Jolić, M., Živadinović, B., & Đurić, V. (2005). Examination of cognitive functions in patients with Parkinsons disease.
624. Stancu, P., d'Esneval, M., Assal, F., Fleury, V., Eshmawey, M., & Unschuld, P. G. (2024). Symptômes psychiatriques de la démence à corps de Lewy. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2024.20.892.1958
625. Stanković, I., & Wenning, G. K. (2014). Neuropsychiatric Manifestations in Atypical Parkinsonian Syndromes. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-09537-0_7
626. Stefani, A., Antelmi, E., Arnaldi, D., Arnulf, I., During, E., Högl, B., Shulman, J., Iranzo, A., Luke, R., Peever, J., Postuma, R. B., Videnović, A., & Gan‐Or, Z. (2025). From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-025-00809-0
627. Stella, F., Canineu, P. R., Souza, L. C. D., & Forlenza, O. V. (2014). C URRENT OPINION Neuropsychiatric symptoms in the prodromal stages of dementia.
628. Stella, F., Radanovic, M., Balthazar, M. L. F., Canineu, P. R., Souza, L. C. D., & Forlenza, O. V. (2014). Neuropsychiatric symptoms in the prodromal stages of dementia. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000050
629. Stevens, S., & Comella, C. (2007). Rapid Eye Movement Sleep Behavior Disorder. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:191
630. Stone, J., & Sharpe, M. (2020). Functional neurological symptom disorder (conversion disorder). Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0133
631. Strippoli, G. F., Montinaro, V., Manno, C. S., Palma, M., Lepore, V., Schena, F., & Pertosa, G. B. (2002). [Chorea in hemodialysis: Is chorea just a neurological syndrome or is it related to uremia or dialysis?].. PubMed.
632. Strupp, M., Kremmyda, O., Adamczyk, C., Böttcher, N., Muth, C., Yip, C. W., & Brémovà-Ertl, T. (2014). Central ocular motor disorders, including gaze palsy and nystagmus. Journal of Neurology. https://doi.org/10.1007/s00415-014-7385-9
633. Sun, M. (2018). Executive functioning: perspectives on neurotrophic activity and pharmacology. Behavioural Pharmacology. https://doi.org/10.1097/fbp.0000000000000427
634. Sundal, C., & Wszołek, Z. K. (2017). CSF1R- Related Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.
635. Suzuki, K., Miyamoto, M., Miyamoto, T., Iwanami, M., Sakuta, H., & Hirata, K. (2012). [Sleep disturbances in patients with Parkinson disease].. PubMed.
636. Svoboda, W. B. (2004). Language regression with epilepsy syndromes. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545092.008
637. Swann, A. C. (2009). Pharmacologic Mood Destabilization: <i>Case Vignettes</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900003898
638. Szoszkiewicz, M., Malendowicz-Major, B., & Żarowski, M. (2020). NARCOLEPSY. Issues of Rehabilitation Orthopaedics Neurophysiology and Sport Promotion – IRONS. https://doi.org/10.19271/irons-000125-2020-33
639. Szűcs, A., Horváth, A., & Anikó, P. (2016). Progress in elucidating the pathophysiological basis of nonrapid eye movement parasomnias: not yet informing therapeutic strategies. Nature and Science of Sleep. https://doi.org/10.2147/nss.s71513
640. Sánchez, V. A., Núñez, F., & Pastoriza, A. R. (2003). Alucinaciones visuales complejas en un paciente con déficit visual severo en ambos ojos (síndrome de Charles Bonnet). Archivos de la Sociedad Española de Oftalmología. https://doi.org/10.4321/s0365-66912003000600008
641. Taboada, J. (2005). El diagnóstico por imagen en el niño con problemas neuropsicológicos. Parte 2. Plasticidad y Restauración Neurológica.
642. Tagai, K., Nagata, T., Shinagawa, S., & Shigeta, M. (2020). Anosognosia in patients with Alzheimer's disease: current perspectives. Psychogeriatrics. https://doi.org/10.1111/psyg.12507
643. Tanrıverdi, M., Düzenli, S., Gündüz, M., Arslantürk, A., & Erekdağ, A. (2024). Investigation of Neurogenic Dysphagia in Different Neurological Diseases. Anadolu Kliniği Tıp Bilimleri Dergisi. https://doi.org/10.21673/anadoluklin.1432672
644. Taskar, V., & Hirshkowitz, M. (2003). Health Effects of Sleep Deprivation. Clinical Pulmonary Medicine. https://doi.org/10.1097/00045413-200301000-00008
645. Tavares, A., & Azeredo, C. (2003). Demência com corpos de Lewy: uma revisão para o psiquiatra. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832003000100004
646. Taylor, C. A. (2003). Neuropsychiatry. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.023
647. Teive, H. A. G., & Arruda, W. O. (2009). Cognitive dysfunction in spinocerebellar ataxias. Dementia & Neuropsychologia. https://doi.org/10.1590/s1980-57642009dn30300002
648. Teune, L. K., & Leenders, K. L. (2012). Molecular Imaging in Parkinson’s Disease. Neuromethods. https://doi.org/10.1007/7657_2012_51
649. Tg, A., An, B., & Ei, G. (2000). [Spectrum of neuropsychological changes in multiple sclerosis].. PubMed.
650. Thaisetthawatkul, P., Fernandes, J. A., Piccione, E., Truong, L., & Dyck, P. J. B. (2017). Inflammatory diabetic neuropathy: helpful diagnostic parameters (P5.132). Neurology. https://doi.org/10.1212/wnl.88.16_supplement.p5.132
651. Tharani, N. M. (2018). Diffusion weighted imaging as a predictor of visual outcome in acute optic neuritis.
652. Thies, T., Muecke, D., Lowit, A., Kalbe, E., Steffen, J., & Barbe, M. T. (2019). Cognitive skills and prominence production : highlighting prominent elements in the speech of patients with Parkinson's disease.
653. Thorburn, D. R., Rahman, J., & Rahman, S. (2014). Mitochondrial DNA-Associated Leigh Syndrome and NARP. University of Washington, Seattle eBooks.
654. Thorpy, M. J., Siegel, J. M., & Dauvilliers, Y. (2024). REM Sleep in Narcolepsy. Sleep Medicine Reviews. https://doi.org/10.1016/j.smrv.2024.101976
655. Théaudin, M., Ochsner, F., Adam, C., Echaniz‐Laguna, A., Magy, L., Fayolle, D., Vicino, A., Hübers, A., & Péréon, Y. (2022). Diagnostiquer une neuropathie des petites fibres. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2022.18.779.803
656. Tito, E., Knapp, B., Bucca, A., & Espiridion, E. D. (2019). A Case Report of Schizoaffective Disorder with Pseudoseizures in a 42-year-old Male. Cureus. https://doi.org/10.7759/cureus.4835
657. Torpy, J. M. (2008). Delirium. JAMA. https://doi.org/10.1001/jama.300.24.2936
658. Townsend, L., Anderson, K. N., Boeve, B. F., McKeith, I. G., & Taylor, J. (2023). Sleep disorders in Lewy body dementia: Mechanisms, clinical relevance, and unanswered questions. Alzheimer s & Dementia. https://doi.org/10.1002/alz.13350
659. Tran, M.-L. N., Grace-Abraham, N., Jaqua, E., & Moore, C. (2025). Sleep in Adults: Parasomnias.. PubMed.
660. Tripathy, K., & Sengupta, T. (2017). Letter re: Transient smartphone blindness: Relevance to misdiagnosis in neurologic practice. Neurology. https://doi.org/10.1212/wnl.0000000000004130
661. Trouillet, R., Gély-Nargeot, M.-C., & Derouesné, C. (2003). [Unawareness of deficits in Alzheimer's disease: a multidimentional approach].. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
662. Uchiyama, M., Suzuki, M., Konno, C., Furihata, R., Osaki, K., Konno, M., & Takahashi, S. (2010). [Management of insomnia and hypersomnia associated with psychiatric disorders].. Psychiatria et neurologia japonica/Seishin shinkeigaku zasshi.
663. Usón, J. R. V. (2005). Aspectos neurofisiológicos de las disfasias. Revista de Neurología. https://doi.org/10.33588/rn.41s01.2005378
664. Usón, J. R. V. (2005). Trastornos generalizados del desarrollo y sueño. Revista de Neurología. https://doi.org/10.33588/rn.41s01.2005377
665. Valikova, T. A., Fyodorova, I. M., & Paimursina, N. Y. (2002). The clinical manifestations of nervous system mesenchyme syphilis. Bulletin of Siberian Medicine. https://doi.org/10.20538/1682-0363-2002-2-77-82
666. Vasilyeva, Y. B. (2019). Clinical Features of Traumatic Brain Injury in Various Kinds of Brain Damage. Russian Sklifosovsky Journal Emergency Medical Care. https://doi.org/10.23934/2223-9022-2019-8-3-295-301
667. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
668. Vellaichamy, T., & Krishnapillai, S. (2019). Analytical study of 100 cases of traumatic optic neuropathy. MedPulse International Journal of Ophthalmology. https://doi.org/10.26611/10091011
669. Ven, V. V. D., & Linden, D. E. (2012). The Role of Mental Imagery in Aberrant Perception: A Neurobiological Perspective. Journal of Experimental Psychopathology. https://doi.org/10.5127/jep.017511
670. Vergano, S. A. S., Sluijs, P. J. V. D., & Santen, G. W. (2019). ARID1B-Related Disorder.
671. Verghese, J. (2000). PTSD, DEMENTIA, AND SLEEP DISORDER: A POSSIBLE ASSOCIATION. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2000.tb04799.x
672. Verma, N., Doctor, D., & Raval, N. (2014). Leigh's Disease: A case Report.
673. Vernino, S., Geschwind, M. D., & Boeve, B. F. (2007). Autoimmune Encephalopathies. The Neurologist. https://doi.org/10.1097/01.nrl.0000259483.70041.55
674. Verny, M., Boller, F., Hugonot-Diener, L., & Saxton, J. (2002). Clinical features and assessment of severe dementia. A review<sup>1</sup>. European Journal of Neurology. https://doi.org/10.1046/j.1468-1331.2002.00356.x
675. Vezzosi, D., Bennet, A., Maïza, J.-C., Buffet, A., Grunenwald, S., Fauvel, J., Courbon, F., Otal, P., Carrère, N., & Caro, P. (2011). Diagnosis and Treatment of Insulinomas in the Adults. InTech eBooks. https://doi.org/10.5772/17452
676. Vigevano, F., & Bartuli, A. (2002). Infantile epileptic syndromes and metabolic etiologies.. PubMed.
677. Villagran, A. M., & Scullin, M. K. (2019). Sleep Disorders and Neurocognition. https://doi.org/10.1093/oxfordhb/9780190664121.013.16
678. Vonsattel, J. P., Cortés, E., & Keller, C. E. (2009). Juvenile Huntington’s disease: neuropathology. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199236121.003.0005
679. Voshaar, R. C. O., Arts, M., Michielsen, P., Petrykiv, S., & Jonge, L. D. (2016). Treatment of Charles Bonnet Syndrome with Continuous Positive Airway Pressure in an Older Adult. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1705
680. Wachholz, P. A., & Masuda, P. Y. (2016). Perseveration as main symptom in dementia syndrome: case report. PAJAR - Pan-American Journal of Aging Research. https://doi.org/10.15448/2357-9641.2015.2.21996
681. Wadsworth, L. P., Lorius, N., Donovan, N. J., Locascio, J. J., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Marshall, G. A. (2012). Neuropsychiatric Symptoms and Global Functional Impairment along the Alzheimers Continuum. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000342119
682. Wali, S., Mithilesh, S., Sheikh, C., Parihar, A. S., & Ganachari, G. M. (2019). A Rare Case Report: Leigh Syndrome. Indian Journal of Pharmacy Practice. https://doi.org/10.5530/ijopp.12.4.59
683. Walker, M. C., & Sander, J. W. (2011). Epilepsy and Sleep Disorders. CRC Press eBooks. https://doi.org/10.1201/b13388-13
684. Webster, J. (2008). Size matters?. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e328307a095
685. White, L. R., Hemmy, L. S., Flanagan, M. E., Kawas, C. H., Corrada, M. M., Edland, S. D., & Montine, T. J. (2018). P1‐111: RESISTANCE, RESERVE, AND RESILIENCE: SYSTEMS THAT DEFEND AGAINST AGE‐RELATED COGNITIVE DECLINE—OBSERVATIONS FROM THE HONOLULU‐ASIA AGING STUDY (HAAS). Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2018.06.114
686. Widyaningsih, H., Lestyari, S. I., Yuliana, A. R., Wanarsih, B. D., Hartini, S., & Faridah, N. (2024). Pemberdayaan lansia melalui program deteksi dini gangguan fungsi kognitif. Jurnal PADE Pengabdian & Edukasi. https://doi.org/10.30867/pade.v6i2.2114
687. Wieling, W., Thijs, R. D., Dijk, N. V., Wilde, A. A., Benditt, D. G., & Dijk, J. G. V. (2009). Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. https://doi.org/10.1093/brain/awp179
688. Wierenga, C. E., & Bondi, M. W. (2011). Dementia and Alzheimer's Disease: What We Know Now. Generations.
689. Wijdicks, E. F. M. (2025). “See Nothing, See Double, See Shapes”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544976.003.0008
690. Williams, L. M., & Gott, C. (2013). What Dimensions of Heterogeneity Are Relevant for Treatment Outcome?. Schizophrenia. https://doi.org/10.7551/mitpress/9780262019620.003.0004
691. Wirz‐Justice, A. (2003). Chronobiology and mood disorders. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2003.5.4/awirzjustice
692. Wolff, A., & O’Driscoll, G. A. (1999). Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk.. PubMed.
693. Wu, D., & Yu, Y. (2012). Electroencephalography (EEG) and Unconsciousness. InTech eBooks. https://doi.org/10.5772/48346
694. Wu, D., Liu, X., Yao, X., Yang, Y., Zhang, J., Yang, H., & Sun, W. (2022). Analysis of electroclinical features of nonconvulsive status epilepticus: a study of four cases. Acta Epileptologica. https://doi.org/10.1186/s42494-021-00073-x
695. Wyman‐Chick, K. A., Chaudhury, P., Bayram, E., Abdelnour, C., Matar, E., Chiu, S., Ferreira, D., Hamilton, C. A., Donaghy, P. C., Rodríguez‐Porcel, F., Toledo, J. B., Habich, A., Barrett, M. J., Patel, B., Jaramillo‐Jimenez, A., Scott, G. D., & Kane, J. (2024). Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians. Neurology and Therapy. https://doi.org/10.1007/s40120-024-00620-x
696. Yakhia, M., König, A., Flier, W. M. V. D., Friedman, L., Robert, P., & David, R. (2014). Actigraphic Motor Activity in Mild Cognitive Impairment Patients Carrying Out Short Functional Activity Tasks: Comparison between Mild Cognitive Impairment with and without Depressive Symptoms. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-131691
697. Yan, R. M., Cardonne, M. M., Reyes, E. J. M., & Leyva, A. G. (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
698. Yang, C., Lin, S., & Cheng, C. (2013). Transient Insomnia Versus Chronic Insomnia: A Comparison Study of Sleep‐Related Psychological/Behavioral Characteristics. Journal of Clinical Psychology. https://doi.org/10.1002/jclp.22000
699. Yang, S.-Y., Kim, Y. H., & Seo, J.-G. (2025). A Patient with Anti-leucine-rich-glioma-inactivated 1 Encephalitis Initially Suspected as Wernicke-Korsakoff Syndrome. Journal of the Korean Neurological Association. https://doi.org/10.17340/jkna.2025.0018
700. Yang, Y., Shi, Y., Schweighauser, M., Zhang, X., Kotecha, A., Murzin, A. G., Garringer, H. J., Cullinane, P. W., Saito, Y., Foroud, T., Warner, T. T., Hasegawa, K., Vidal, R., Murayama, S., Révész, T., Ghetti, B., Hasegawa, M., Lashley, T., Scheres, S. H. W., & Goedert, M. (2022). Cryo-EM structures of α-synuclein filaments from Parkinson’s disease and dementia with Lewy bodies. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2022.07.12.499706
701. Yoshimura, M. (1997). [Diffuse Lewy body disease].. PubMed.
702. Young, A., & Johnston, J. L. (2024). Pearls &amp; Oy-sters: Ocular Myasthenia Gravis. Neurology. https://doi.org/10.1212/wnl.0000000000209260
703. Young, M. J., Edlow, B. L., & Bodien, Y. G. (2024). Covert consciousness. Neurorehabilitation. https://doi.org/10.3233/nre-230123
704. Yuan, J., Peng, B., You, H., & Zhang, W. (2011). [Clinical and neuroimaging features of central nervous system impairments in acute intermittent porphyria].. PubMed.
705. Zemla, J. C. (2024). Increased reliance on heuristic thinking in mild cognitive impairment. Aging Neuropsychology and Cognition. https://doi.org/10.1080/13825585.2024.2405506
706. Zhang, F., Luo, A., Liao, S., Liu, M., Zhang, J., & Xu, Z. (2024). Progress of non‐motor symptoms in early‐onset Parkinson's disease. Ibrain. https://doi.org/10.1002/ibra.12180
707. Zhang, T., Yu, S., Guo, P., Du, Y., Hu, Y., Piao, Y., Zuo, L., Lian, T., Wang, R., Yu, Q.-J., Jin, Z., & Zhang, W. (2016). Nonmotor symptoms in patients with Parkinson disease. Medicine. https://doi.org/10.1097/md.0000000000005400
708. Zhang, Y., Zhong, S., & Lai, S. (2019). The brain imaging mechanisms of visual cognitive impairment in depression. Zhonghua xingwei yixue yu naokexue zazhi. https://doi.org/10.3760/cma.j.issn.1674-6554.2019.10.017
709. Zhao, S. S., Mutch, K., Elsone, L., Miller, J., & Jacob, A. (2014). An unusual case of 'itchy paralysis’: neuromyelitis optica presenting with severe neuropathic itch. Practical Neurology. https://doi.org/10.1136/practneurol-2014-000936
710. Zhurkova, N. V., Volgina, S. Y., Gamirova, R., & Solovyeva, N. A. (2022). Early diagnostics of motor disorders in children: an interdisciplinary approach. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). https://doi.org/10.21508/1027-4065-2022-67-5-225-230
711. Zielinski, M. R., Systrom, D. M., & Rose, N. R. (2019). Fatigue, Sleep, and Autoimmune and Related Disorders. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2019.01827
712. Zou, H., Zhou, H., Yan, R., Yao, Z., & Lu, Q. (2022). Chronotype, circadian rhythm, and psychiatric disorders: Recent evidence and potential mechanisms. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2022.811771
713. Zwiernik, J., Zwiernik, B., Cebulski, Z., & Siwek, T. (2011). New symptoms in a patient with diagnosed porphyria – untypical clinical course or another disease? Extended differential diagnosis of multiple sclerosis. Polish Annals of Medicine. https://doi.org/10.1016/s1230-8013(11)70028-5
714. Çarman, K. B., Yimenicioğlu, S., Ekici, A., & Yakut, A. (2012). Sjogren-Larsson Syndrome: A Rare Differential Diagnosis of Cerebral Palsy. International Journal of Clinical Pediatrics.
715. Šonka, K. (2019). Sleep and its disturbances in neurology.. PubMed.